Document:

<PAGE>

                                                                    Exhibit 10.1

                          SECURITIES PURCHASE AGREEMENT

                  SECURITIES PURCHASE AGREEMENT (the "AGREEMENT"), dated as of
September 29, 2000, by and among DAMARK International, Inc., a Minnesota
corporation, with headquarters located at 7101 Winnetka Avenue North,
Minneapolis, Minnesota 55428 (the "COMPANY"), and the investors listed on the
Schedule of Buyers attached hereto (individually, a "BUYER" and collectively,
the "BUYERS").

                  WHEREAS:

                  A.       The Company and the Buyers are executing and
delivering this Agreement in reliance upon the exemption from securities
registration afforded by Rule 506 of Regulation D ("REGULATION D") as
promulgated by the United States Securities and Exchange Commission (the "SEC")
under the Securities Act of 1933, as amended (the "1933 ACT");

                  B.       The Company has authorized the following new series
of its preferred stock, par value $.01 per share (the "PREFERRED STOCK"): the
Company's Series D Convertible Preferred Stock ("SERIES D PREFERRED STOCK")
which shall be convertible into shares of the Company's Class A Common Stock,
$.01 par value per share (the "COMMON STOCK") (as converted, the "CONVERSION
SHARES"), in accordance with the terms of the Company's Certificate of
Designations, Preferences and Rights in the form attached hereto as EXHIBIT A
(the "CERTIFICATE OF DESIGNATIONS").

                  C.       The Company shall authorize as of the Closing the
issuance of Common Stock Purchase Warrants (the "WARRANTS"), in the form
attached hereto as EXHIBIT B, to acquire shares of Common Stock (such shares of
Common Stock issued upon exercise of the Warrants are hereinafter referred to as
the "WARRANT SHARES", and together with the Series D Preferred Shares (as
defined below), the Warrants, the Conversion Shares, and the Dividend Shares (as
defined below), the "SECURITIES");

                  D.       The Buyers wish to purchase, upon the terms and
conditions stated in this Agreement, an aggregate of $20 million of Series D
Preferred, in the respective amounts set forth opposite each Buyer's name on the
Schedule of Buyers; and to receive in consideration for such purchase the
Warrants to purchase shares of Common Stock in the respective amounts set forth
opposite each Buyer's name in the Schedule of Buyers, subject to adjustment as
provided in the Warrants; and

                  E.       Contemporaneously with the execution and delivery of
this Agreement, the parties hereto are executing and delivering a Registration
Rights Agreement in the form attached hereto as EXHIBIT C (the "REGISTRATION
RIGHTS AGREEMENT") pursuant to which the Company has agreed to provide certain
registration rights under the 1933 Act and the rules and regulations promulgated
thereunder, and applicable state securities laws.

<PAGE>

                  NOW, THEREFORE, the Company and the Buyers hereby agree as
follows:

                  1.       PURCHASE AND SALE OF SERIES D PREFERRED STOCK AND
WARRANTS.

                           a.       PURCHASE OF SERIES D PREFERRED STOCK.
Subject to the satisfaction (or waiver) of the conditions set forth in Sections
6 and 7 below, the Company shall issue and sell to the Buyers and the Buyers
shall purchase from the Company an aggregate of 200,000 shares of Series D
Preferred Stock (the "SERIES D PREFERRED SHARES"), in the respective amounts set
forth opposite each Buyer's name on the Schedule of Buyers (the "CLOSING"). The
per share purchase price (the "PURCHASE PRICE") of the Preferred Shares shall be
$100.00 or an aggregate purchase price of $20 million. On the Closing Date (as
defined below) the Company shall deliver to each Buyer a stock certificate(s)
representing such number of Series D Preferred Shares which such Buyer is then
purchasing (as indicated opposite such Buyer's name on the Schedule of Buyers),
duly executed on behalf of the Company and registered in the name of such Buyer
or its designee (the "STOCK CERTIFICATES").

                           b.       CLOSING DATE. The date and time of the
Closing (the "CLOSING DATE") shall be 10:00 a.m. Eastern Standard Time on
September 29, 2000, subject to notification of satisfaction (or waiver) of the
conditions to the Closing set forth in Sections 6 and 7 below (or such later
date as is mutually agreed to by the Company and the Buyers). The Closing shall
occur on the Closing Date at the offices of Schulte Roth & Zabel LLP, 900 Third
Avenue, New York, New York 10022.

                           c.       FORM OF PAYMENT. On the Closing Date, each
Buyer shall pay the Company the Purchase Price for the Series D Preferred Shares
to be issued and sold to such Buyer at the Closing, by wire transfer of
immediately available funds in accordance with the Company's written wire
instructions provided in writing to the Buyers at least two days prior to the
Closing Date.

                           d.       WARRANTS. In consideration of the purchase
of the Series D Preferred Shares, the Company shall on the Closing Date issue
and deliver to each Buyer, Warrants to purchase in the aggregate seven hundred
and seventy-two thousand seven hundred ninety eight (772,798) additional shares
of Common Stock in the respective amounts set forth opposite each Buyer's name
on the Schedule of Buyers.

                  2.       BUYER'S REPRESENTATIONS AND WARRANTIES.

                  Each Buyer represents and warrants with respect to only itself
that:

                           a.       INVESTMENT PURPOSE. Such Buyer (i) is
purchasing the Series D Preferred Shares and the Warrants and (ii) upon
conversion of the Series D Preferred Shares and exercise of the Warrants, will
acquire the Conversion Shares and Warrant Shares, respectively, then issuable
for its own account for investment only and not with a present view towards, or
for resale in connection with, the public sale or distribution thereof, except
pursuant to sales registered or exempted under the 1933 Act;

                                      -2-
<PAGE>

provided, however, that by making the representations herein, such Buyer does
not agree to hold any Securities for any minimum or other specific term and
reserves the right to dispose of the Securities at any time in accordance with
or pursuant to a registration statement or an exemption under the 1933 Act.

                           b.       ACCREDITED INVESTOR STATUS. Such Buyer is an
"accredited investor" as that term is defined in Rule 501(a) of Regulation D.

                           c.       RELIANCE ON EXEMPTIONS. Such Buyer
understands that the Series D Preferred Shares and Warrants are being offered
and sold to it in reliance on specific exemptions from the registration
requirements of United States federal and state securities laws and that the
Company is relying in part upon the truth and accuracy of, and such Buyer's
compliance with, the representations, warranties, agreements, acknowledgments
and understandings of such Buyer set forth herein in order to determine the
availability of such exemptions and the eligibility of such Buyer to acquire the
Series D Preferred Shares and the Warrants.

                           d.       INFORMATION. Such Buyer and its advisors, if
any, have been furnished with all materials relating to the business, finances
and operations of the Company and materials relating to the offer and sale of
the Series D Preferred Shares and the Warrants which have been specifically
requested by such Buyer. Such Buyer and its advisors, if any, have been afforded
the opportunity to ask questions of the Company. Neither such inquiries nor any
other due diligence investigations conducted by such Buyer or its advisors, if
any, or its representatives shall modify, amend or affect such Buyer's right to
rely on the Company's representations and warranties contained in Section 3
below.

                           e.       NO GOVERNMENTAL REVIEW. Such Buyer
understands that no United States federal or state agency or any other
government or governmental agency has passed on or made any recommendation or
endorsement of the Series D Preferred Shares and the Warrants or the fairness or
suitability of the investment in the Securities nor have such authorities passed
upon or endorsed the merits of the offering of the Series D Preferred Shares and
the Warrants.

                           f.       TRANSFER OR RESALE. Such Buyer understands
that except as provided in the Registration Rights Agreement: (i) the Securities
have not been and are not being registered under the 1933 Act or any state
securities laws, and may not be offered for sale, sold, assigned or transferred
unless (A) subsequently registered thereunder, (B) such Buyer shall have
delivered to the Company an opinion of counsel, in a generally acceptable form,
to the effect that such Securities to be sold, assigned or transferred may be
sold, assigned or transferred pursuant to an exemption from such registration,
or (C) such securities can be sold, assigned or transferred pursuant to Rule 144
promulgated under the 1933 Act (or a successor rule thereto) ("RULE 144"); (ii)
any sale of such securities made in reliance on Rule 144 may be made only in
accordance with the terms of Rule 144 and further, if Rule 144 is not
applicable, any resale of such securities under circumstances in which the
seller (or the person through whom the sale is made) may be deemed to be an
underwriter (as that term is defined in the 1933 Act) may

                                      -3-
<PAGE>

require compliance with some other exemption under the 1933 Act or the rules and
regulations of the SEC thereunder; and (iii) neither the Company nor any other
person is under any obligation to register such securities under the 1933 Act or
any state securities laws or to comply with the terms and conditions of any
exemption thereunder.

                           g.       LEGENDS. Such Buyer understands that the
certificates or other instruments representing the Series D Preferred Shares and
the Warrants, and, until such time as the sale of the Conversion Shares and the
Warrant Shares have been registered under the 1933 Act as contemplated by the
Registration Rights Agreement, the stock certificates representing the
Conversion Shares and the Warrant Shares, except as set forth below, shall bear
a restrictive legend in substantially the following form:

         THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN
         REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR
         ANY STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED
         FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF AN
         EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE
         SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE
         SECURITIES LAWS, OR AN APPLICABLE EXEMPTION TO THE
         REGISTRATION REQUIREMENTS OF SUCH ACT AND SUCH LAWS.

The legend set forth above shall be removed and the Company shall issue a
certificate without such legend to the holder of any Securities upon which it is
stamped, if (i) any such Securities are registered for sale under the 1933 Act,
(ii) in connection with a sale transaction, such holder provides the Company
with an opinion of counsel, in a generally acceptable form, to the effect that a
public sale, assignment or transfer of such Securities may be made without
registration under the 1933 Act, or (iii) any of the Securities can be sold
pursuant to Rule 144 without any restriction as to the number of securities
acquired as of a particular date that can then be immediately sold. Each Buyer
acknowledges, covenants and agrees to sell any of the Securities represented by
a certificate(s) from which the legend has been removed, only pursuant to (i) a
registration statement effective under the 1933 Act, or (ii) advice of counsel
that such sale is exempt from registration required by Section 5 of the 1933
Act. In the event the above legend is removed from any of the Securities, the
Company may, upon reasonable advance notice to the holder, require that the
above legend be placed on any of the Securities that cannot then be sold
pursuant to an effective registration statement or Rule 144(k) under the 1933
Act (or any successor rule thereto).

                           h.       AUTHORIZATION; ENFORCEMENT. This Agreement
has been duly and validly authorized, executed and delivered on behalf of such
Buyer and is a valid and binding agreement of such Buyer enforceable in
accordance with its terms, subject as to enforceability to general principles of
equity and to applicable bankruptcy, insolvency, reorganization, moratorium,
liquidation and other similar laws relating to, or affecting generally, the
enforcement of applicable creditors' rights and remedies.

                                      -4-
<PAGE>

                  3.       REPRESENTATIONS AND WARRANTIES OF THE COMPANY AND ITS
                           SUBSIDIARIES.

                           The Company and its subsidiaries represent and
warrant to each of the Buyers that:

                           a.       ORGANIZATION AND QUALIFICATION. The Company
and its subsidiaries (a complete list of which is set forth in Schedule 3(a))
are corporations duly organized and validly existing in good standing under the
laws of the jurisdiction in which they are incorporated, and have the requisite
corporate power to own their properties and to carry on their business as now
being conducted. Each of the Company and its subsidiaries is duly qualified as a
foreign corporation to do business and is in good standing in every jurisdiction
in which the nature of the business conducted by it makes such qualification
necessary, except to the extent that the failure to be so qualified or be in
good standing would not have a Material Adverse Effect and all of which
jurisdictions in which either the Company or its subsidiaries is or believes it
should be duly qualified is set forth on Schedule 3(a) hereto. "MATERIAL ADVERSE
EFFECT" means any material adverse effect on (i) the business, properties,
operations, condition (financial or otherwise), results of operations or
prospects of the Company and its subsidiaries taken as a whole, (ii) on the
ability of the Company to perform its obligations hereunder, under the
Certificate of Designations, the Registration Rights Agreement, the Warrants or
under the agreements or instruments to be entered into or filed in connection
herewith or therewith, or (iii) the Securities.

                           b.       AUTHORIZATION; ENFORCEMENT; COMPLIANCE WITH
OTHER INSTRUMENTS. (I) (i) The Company has the requisite corporate power and
authority to enter into and perform its obligations under this Agreement and the
Registration Rights Agreement, to issue, sell and perform its obligations with
respect to the Series D Preferred Shares and the Warrants in accordance with the
terms hereof, the Certificate of Designations, the Series D Preferred Shares and
the Warrants, as applicable, and to issue the Conversion Shares and the Warrant
Shares upon conversion of the Series D Preferred Shares and the exercise of the
Warrants, respectively, in accordance with the Certificate of Designations and
the Warrants, respectively, (ii) the execution and delivery of this Agreement,
the Series D Preferred Shares, the Warrants and the Registration Rights
Agreement by the Company and the consummation by it of the transactions
contemplated hereby and thereby, including, without limitation, the issuance of
the Series D Preferred Shares and the Warrants and the reservation for issuance
and the issuance of the Conversion Shares issuable upon conversion of the Series
D Preferred Shares and of the Common Stock that may be issued for payment of
dividends on the Series D Preferred Shares (the "DIVIDEND SHARES") in accordance
with the terms of the Certificate of Designations and the Warrant Shares upon
exercise of the Warrants have been duly authorized by the Company's Board of
Directors and no further consent or authorization is required by the Company,
its Board of Directors or its stockholders, (iii) this Agreement, the
Registration Rights Agreement, the certificates for the Series D Preferred
Shares and the Warrants have been duly executed and delivered by the Company,
and (iv) this Agreement, the Registration Rights Agreement, certificates for the
Series D Preferred Shares and the Warrants constitute the valid and binding
obligations of the

                                      -5-
<PAGE>

Company enforceable against the Company in accordance with their terms, (v)
prior to the Closing Date, the Certificate of Designations will have been filed
with the Secretary of State of the State of Minnesota and (vi) this Agreement,
the Certificate of Designations, the Registration Rights Agreement and the
Warrants are in full force and effect, enforceable against the Company in
accordance with their respective terms, except as such enforceability may be
limited by general principles of equity or applicable bankruptcy, insolvency,
reorganization, moratorium, liquidation or similar laws relating to, or
affecting generally, the enforcement of creditors' rights and remedies.

                                    (II)     ClickShip Direct, Inc.
("ClickShip"), a wholly-owned subsidiary of the Company, has the requisite
corporate power and authority to enter into and perform its obligations under
the Registration Rights Agreement attached hereto as EXHIBIT D (the "CLICKSHIP
REGISTRATION RIGHTS AGREEMENT"), to issue and perform its obligations with
respect to the Warrants in the form attached hereto as EXHIBIT E (the "CLICKSHIP
WARRANTS") in accordance with the terms hereof, the ClickShip Registration
Rights Agreement and the ClickShip Warrants, as applicable, and to issue the
shares of ClickShip's common stock issuable upon exercise of the ClickShip
Warrant (the "CLICKSHIP WARRANT SHARES"), respectively, in accordance with the
ClickShip Warrants. The execution and delivery of the ClickShip Registration
Rights Agreement and the ClickShip Warrants by ClickShip and the consummation by
ClickShip of the transactions contemplated hereby and thereby, including,
without limitation, the issuance of the ClickShip Warrants and the reservation
for issuance and the issuance of the ClickShip Warrant Shares upon exercise of
the ClickShip Warrants have been duly authorized and no further consent or
authorization is required by the Company, its Board of Directors or its
stockholders, or the ClickShip Board of Directors. The ClickShip Registration
Rights Agreement has been duly executed and delivered by ClickShip and the
ClickShip Warrants will be duly executed and delivered by ClickShip upon
issuance. The ClickShip Registration Rights Agreement constitute and, upon
issuance, the ClickShip Warrants will constitute the valid and binding
obligations of ClickShip enforceable against ClickShip in accordance with their
terms and (v) the ClickShip Registration Rights Agreement and, upon issuance,
the ClickShip Warrants will be upon execution in full force and effect,
enforceable against ClickShip in accordance with its terms, except in each case
as such enforceability may be limited by general principles of equity or
applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or
similar laws relating to, or affecting generally, the enforcement of creditors'
rights and remedies.

                           c.       CAPITALIZATION AND INDEBTEDNESS. As of the
date hereof and immediately prior to the issuance of the Series D Preferred
Shares and Warrants hereunder, the authorized capital stock of the Company
consists of 20,000,000 shares of Common Stock, of which as of the date hereof,
5,847,519 shares are issued and outstanding, 2,000,000 shares of Class B Common
Stock (the "Class B Common Stock"), of which as of the date hereof, no shares
are issued and outstanding, 2,400,000 shares of Series A Convertible Preferred
Stock ("Series A Preferred Stock"), of which as of the date hereof, no shares
are issued and outstanding, 1,650,000 shares of Series B Convertible Non-Voting
Preferred Stock ("Series B Preferred Stock"), of which as of the date hereof, no
shares are issued and outstanding, and 400,000 shares of Series C Junior

                                      -6-
<PAGE>

Participating Preferred Stock ("Series C Preferred Stock" and collectively with
the Series A Preferred Stock and Series B Preferred Stock called the "Company
Preferred"), of which as of the date hereof no shares are issued and
outstanding. All of the outstanding shares have been validly issued and are
fully paid and nonassessable. No shares of Common Stock, Class B Common Stock,
Company Preferred or Preferred Stock are subject to preemptive rights or any
other similar rights or any liens or encumbrances suffered or permitted by the
Company. Except as set forth on Schedule 3(c), as of the date hereof, (i) there
are no outstanding options, warrants, scrip, rights to subscribe to, calls or
commitments of any character whatsoever relating to, or securities or rights
convertible into, any shares of capital stock of the Company or any of its
subsidiaries, or contracts, commitments, understandings or arrangements by which
the Company or any of its subsidiaries is or may become bound to issue
additional shares of capital stock of the Company or any of its subsidiaries,
(ii) there are no outstanding debt securities, notes, credit agreements, or
other agreements, documents or instruments evidencing indebtedness of the
Company or any of its subsidiaries or by which the Company or any of its
subsidiaries is or may become bound and (iii) there are no agreements or
arrangements under which the Company or any of its subsidiaries is obligated to
register the sale of any of their securities under the 1933 Act (except the
Registration Rights Agreement and the ClickShip Registration Rights Agreement).
There are no securities or instruments containing anti-dilution or similar
provisions that will be triggered by the issuance of any of the Securities or
the ClickShip Warrants or ClickShip Warrant Shares as described in this
Agreement. The Company has furnished to the Buyer true and correct copies of
each of the Company's and ClickShip's articles of incorporation, as amended and
as in effect on the date hereof (the "CERTIFICATE OF INCORPORATION"), and each
of the Company's and ClickShip's By-laws, as in effect on the date hereof (the
"BY-LAWS"), and the terms of all securities convertible into or exercisable for
Common Stock, Class B Common Stock or Preferred Stock and the material rights of
the holders thereof in respect thereto.

                           d.       ISSUANCE OF SECURITIES. The Securities and
the ClickShip Warrants and ClickShip Warrant Shares are duly authorized and,
upon issuance in accordance with the terms hereof and the ClickShip Warrants,
the Series D Preferred Shares, the Warrants and the ClickShip Warrants shall be
(i) validly issued, fully paid and non-assessable, (ii) free from all taxes,
liens and charges with respect to the issue thereof, and shall not be subject to
preemptive rights or other similar rights of shareholders of the Company or
ClickShip, as applicable, and (iii) entitled to the rights and preferences set
forth in the Certificate of Designations, the Warrants and the ClickShip
Warrants, respectively. An aggregate of 5,250,000 shares of Common Stock have
been authorized and reserved by the Company to provide for (A) the issuance upon
conversion of the Series D Preferred Shares and exercise of the Warrants and (B)
the issuance of the Dividend Shares have been authorized and reserved by the
Company. Upon conversion or exercise in accordance with the Certificate of
Designations and the Warrants, as applicable, the Conversion Shares and Warrant
Shares, and upon issuance in accordance with the terms of the Certificate of
Designations, the Dividend Shares, will be validly issued, fully paid and
nonassessable and free from all taxes, liens and charges with respect to the
issue thereof, with the holders being entitled to all rights accorded to a
holder of Common Stock. Upon exercise in accordance with the ClickShip Warrants,
the

                                      -7-
<PAGE>

ClickShip Warrant Shares will be validly issued, fully paid and nonassessable
and free from all taxes, liens and charges with respect to the issue thereof,
with the holders being entitled to all rights accorded to a holder of the common
stock of ClickShip.

                           e.       NO CONFLICTS. The execution, delivery and
performance of this Agreement, the Registration Rights Agreement, the
Certificate of Designations and the Warrants by the Company, and the ClickShip
Registration Rights Agreement and the ClickShip Warrants by ClickShip and the
consummation by the Company and ClickShip, as applicable, of the transactions
contemplated hereby and thereby (including, without limitation, the issuance of
the Securities, the Dividend Shares and the ClickShip Warrants and ClickShip
Warrant Shares) will not (i) result in a violation of the Bylaws, the
Certificate of Incorporation and the Certificate of Designations, Preferences
and Rights of any outstanding series of Preferred Stock of the Company or any of
its subsidiaries, or (ii) except as disclosed in Schedule 3(e), violate or
conflict with, or result in a breach of any provision of, or constitute a
default (or an event which with notice or lapse of time or both would become a
default) under, or give to others any rights of termination, amendment,
acceleration or cancellation of, any material agreement, indenture or instrument
to which the Company or any of its subsidiaries is a party, or result in a
violation of any law, rule, regulation, order, judgment or decree (including
U.S. federal and state securities laws and regulations and the rules and
regulations of the principal market or exchange on which the Common Stock is
traded or listed or on which the common stock of ClickShip will be traded or
listed) applicable to the Company or any of its subsidiaries or by which any
property or asset of the Company or any of its subsidiaries is bound or
affected. Neither the Company nor any of its subsidiaries is in violation of any
term of or in default under its Certificate of Incorporation, any Certificate of
Designations, Preferences and Rights of any outstanding series of Preferred
Stock or By-laws or their organizational charter or by-laws, respectively, or in
violation of any term of or in default under any contract, agreement, mortgage,
indebtedness, indenture, instrument, judgment, decree or order or any statute,
rule or regulation applicable to the Company or its subsidiaries except where
such defaults and violations would not in the aggregate have a Material Adverse
Effect. The business of the Company and its subsidiaries is not being conducted
in violation of any law, ordinance or regulation of any governmental entity
except where such violations would not in the aggregate have a Material Adverse
Effect. Except as specifically contemplated by this Agreement and as required
under the 1933 Act, the Company is not required to obtain any consent,
authorization or order of, or make any filing or registration with, any court or
governmental or regulatory or self-regulatory agency in order for it to execute,
deliver or perform any of its obligations under or contemplated by this
Agreement, the Certificate of Designations, the Registration Rights Agreement or
the Warrants in accordance with the terms hereof or thereof. Except as required
under the 1933 Act, ClickShip is not required to obtain any consent,
authorization or order of, or make any filing or registration with, any court or
governmental or regulatory or self-regulatory agency in order for it to execute,
deliver or perform any of its obligations under or contemplated by the ClickShip
Registration Rights Agreement or the ClickShip Warrants in accordance with the
terms thereof. All consents, authorizations, orders, filings and registrations
which the Company or any of its subsidiaries is required to obtain pursuant to
the preceding two sentences have been obtained or effected on or prior to the
date

                                      -8-
<PAGE>

hereof. The Company is not in violation of the listing requirements of the
NASDAQ National Market and does not reasonably anticipate that the Common Stock
will be delisted by the NASDAQ National Market in the foreseeable future. The
Company and its subsidiaries are unaware of any facts or circumstances which
might give rise to any of the foregoing.

                           f.       SEC DOCUMENTS; FINANCIAL STATEMENTS. Since
December 31, 1998 the Company has filed all reports, schedules, forms,
statements and other documents required to be filed by it with the SEC pursuant
to the reporting requirements of the Securities Exchange Act of 1934, as amended
(the "1934 ACT") (all of the foregoing filed prior to the date hereof and all
exhibits included therein and financial statements and schedules thereto and
documents incorporated by reference therein being hereinafter referred to as the
"SEC DOCUMENTS"). The Company (i) has delivered or made available to each Buyer
or its representative true and complete copies of the SEC Documents to the
extent that each Buyer or its representative has requested any such SEC
Documents from the Company and (ii) agrees to deliver or make available to each
Buyer or its representative true and complete copies of any additional SEC
Documents, upon request. As of their respective dates, the SEC Documents
complied in all material respects with the requirements of the 1934 Act and the
rules and regulations of the SEC promulgated thereunder applicable to the SEC
Documents, and none of the SEC Documents, at the time they were filed with the
SEC, contained any untrue statement of a material fact or omitted to state a
material fact required to be stated therein or necessary in order to make the
statements therein, in light of the circumstances under which they were made,
not misleading. As of their respective dates, the financial statements of the
Company included in the SEC Documents complied as to form in all material
respects with applicable accounting requirements and the published rules and
regulations of the SEC with respect thereto. Such financial statements have been
prepared in accordance with generally accepted accounting principles,
consistently applied during the periods involved (except (i) as may be otherwise
indicated in such financial statements or the notes thereto, or (ii) in the case
of unaudited interim statements, to the extent they may exclude footnotes or may
be condensed or summary statements) and fairly present in all material respects
the financial position of the Company as of the dates thereof and the results of
its operations and cash flows for the periods then ended (subject, in the case
of unaudited statements, to normal year-end audit adjustments). No other
information provided by or on behalf of the Company to any Buyer which is not
included in the SEC Documents, including, without limitation, information
referred to in Section 2(d) of this Agreement, contains any untrue statement of
a material fact or omits to state any material fact necessary in order to make
the statements therein, in the light of the circumstances under which they are
or were made, not misleading.

                           g.       ABSENCE OF CERTAIN CHANGES. Except as
expressly set forth in Schedule 3(g) since December 31, 1999, there has been no
material adverse change and no material adverse development in the business,
properties, operations, condition (financial or otherwise), results of
operations or prospects of the Company and its subsidiaries taken as a whole.
The Company has not taken any steps, and does not currently expect to take any
steps, to seek protection pursuant to any bankruptcy law nor

                                      -9-
<PAGE>

does the Company or its subsidiaries have any knowledge or reason to believe
that its creditors intend to initiate involuntary bankruptcy proceedings.

                           h.       ABSENCE OF LITIGATION. There is no action,
suit, proceeding, inquiry or investigation before or by any court, public board,
government agency, self-regulatory organization or body pending or, to the
knowledge of the Company or any of its subsidiaries, threatened against or
affecting the Company or its subsidiaries or their respective directors or
officers, or the Common Stock, wherein an unfavorable decision, ruling or
finding would, to the knowledge of the Company, individually or in the
aggregate, have a Material Adverse Effect. Schedule 3(h) contains a complete
list and summary description of any pending, or to the knowledge of the Company,
threatened proceeding against or affecting the Company or any of its
subsidiaries, without regard to whether it could have a Material Adverse Effect.

                           i.       ACKNOWLEDGMENT REGARDING BUYERS' PURCHASE OF
THE SECURITIES. The Company acknowledges and agrees that each of the Buyers is
acting solely in the capacity of arm's length purchaser with respect to this
Agreement and the transactions contemplated hereby. The Company further
acknowledges that each Buyer is not acting as a financial advisor or fiduciary
of the Company (or in any similar capacity) with respect to this Agreement and
the transactions contemplated hereby and any advice given by any of the Buyers
or any of their respective representatives or agents in connection with this
Agreement and the transactions contemplated hereby is merely incidental to such
Buyer's purchase of the Securities. The Company further represents to each Buyer
that the Company's decision to enter into this Agreement has been based solely
on the independent evaluation by the Company and its representatives.

                           j.       NO GENERAL SOLICITATION. Neither the
Company, nor any of its affiliates, nor any person acting on its or their
behalf, has engaged in any form of general solicitation or general advertising
(within the meaning of Regulation D under the 1933 Act) in connection with the
offer or sale of any of the Securities offered hereby.

                           k.       NO INTEGRATED OFFERING. Neither the Company,
nor any of its affiliates, nor any person acting on its or their behalf has,
directly or indirectly, made any offers or sales of any security or solicited
any offers to buy any security, under circumstances that would require
registration of any of the Securities under the 1933 Act or cause the offering
of any of the Securities to be integrated with prior offerings by the Company
for purposes of the 1933 Act or any applicable shareholder approval provisions,
including, without limitation, under the rules and regulations of the National
Association of Securities Dealers Automated Quotation System ("NASDAQ").

                           l.       EMPLOYMENT MATTERS; ERISA MATTERS. The
Company and its subsidiaries are in compliance with all federal, state, local
and foreign laws and regulations respecting employment and employment practices,
terms and conditions of employment and wages and hours except where failure to
be in compliance would not have a Material Adverse Effect. There are no pending
investigations involving the Company or any of its subsidiaries by the U.S.
Department of Labor or any other governmental agency responsible for the
enforcement of such federal, state, local or

                                      -10-
<PAGE>

foreign laws and regulations. There is no unfair labor practice charge or
complaint against the Company or any of its subsidiaries pending before the
National Labor Relations Board or any strike, picketing, boycott, dispute,
slowdown or stoppage pending or threatened against or involving the Company or
any of its subsidiaries. Except as set forth in Schedule 3(l), no representation
question exists respecting the employees of the Company or any of its
subsidiaries, and no collective bargaining agreement or modification thereof is
currently being negotiated by the Company or any of its subsidiaries. No
grievance or arbitration proceeding is pending under any expired or existing
collective bargaining agreements of the Company or any of its subsidiaries. No
material labor dispute with the employees of the Company or any of its
subsidiaries exists or, to the knowledge of the Company, is imminent. Schedule
3(l) sets forth a list of every employee benefit plan (whether or not subject to
the Employee Retirement Income Security Act of 1974, as amended ("ERISA"))
maintained or contributed to by the Company or any of member of its controlled
group (determined in accordance with Section 4001(a)(14) of ERISA) (collectively
the "Plans"). Except for such failures that would not, individually or in the
aggregate, result in a Material Adverse Effect, each of the Plans have been
maintained and administered in accordance with their terms, ERISA, the Internal
Revenue Code of 1986, as amended (the "CODE") and other applicable laws. None of
the Plans is subject to Title IV of ERISA and no Plan is a multiemployer plan
(within the meaning of Section 3(37) of ERISA). Each Plan intended to qualify
under Section 401(a) or 501(c)(9) of the Code has received a favorable
determination or approval letter from the Internal Revenue Service regarding its
qualification under such section and no event has occurred which cause any such
Plan to lose its qualification.

                           m.       INTELLECTUAL PROPERTY RIGHTS. The Company
and its subsidiaries own or possess the requisite rights or licenses to use all
trademarks, trade names, service marks, service mark registrations, service
names, patents, patent rights, copyrights, inventions, licenses, approvals,
governmental authorizations, trade secrets and rights (collectively
"INTELLECTUAL PROPERTY RIGHTS") necessary to conduct their respective businesses
as now conducted and as presently contemplated to be operated in the future.
None of the Intellectual Property Rights or other intellectual property rights
have expired or terminated, or are expected to expire or terminate in the near
future. The Company and its subsidiaries do not have any knowledge of any event,
fact or circumstance relating to (i) any infringement by the Company or its
subsidiaries of any trademarks, trade names, service marks, service mark
registrations, service names, patents, patent rights, copyrights, inventions,
licenses, approvals, governmental authorizations, trade secrets or other similar
rights of others, or of any such development of similar or identical trade
secrets or technical information by others or (ii) any person or entity now
infringing any Intellectual Property Rights or other similar rights or any such
development of similar or identical trade secrets or technical information owned
or used by the Company or any of its subsidiaries or (iii) any person or entity
now infringing any Intellectual Property Rights or other similar rights or any
such development of similar or identical trade secrets or other infringement.
There is no claim, action or proceeding being made or brought against, or to the
Company's knowledge, being threatened against, the Company or its subsidiaries
regarding any trademarks, trade names, service marks, service mark
registrations, service names, patents, patent rights, copyrights, inventions,
licenses, approvals, governmental authorizations, trade secrets or other similar
rights of

                                      -11-
<PAGE>

others, or of any such development of similar or identical trade secrets or
technical information by others. The Company and its subsidiaries have taken
reasonable security measures to protect the secrecy, confidentiality and value
of all of their Intellectual Property Rights.

                           n.       ENVIRONMENTAL LAWS. (i) The Company and its
subsidiaries (A) are in compliance with any and all Environmental Laws, (B) have
received all permits, licenses or other approvals required of them under
applicable Environmental Laws to conduct their respective businesses, and (C)
are in compliance with all terms and conditions of any such permit, license or
approval, except in each case where the failure of the Company and its
subsidiaries would not, individually or in the aggregate, have a Material
Adverse Effect. With respect to the Company and/or its subsidiaries (A) there
are no past or present releases of any material into the environment, actions,
activities, circumstances, conditions, events, incidents, or contractual
obligations which may give rise to any common law environmental liability or any
liability under any Environmental Law in any material respect and (B) neither
the Company nor any of its subsidiaries has received any notice with respect to
the foregoing, nor is any action pending or to the Company's knowledge,
threatened in connection with the foregoing. The term "ENVIRONMENTAL LAWS" means
all federal, state, local or foreign laws relating to pollution or protection of
human health or the environment (including, without limitation, ambient air,
surface water, groundwater, land surface or subsurface strata), including,
without limitation, laws relating to emissions, discharges, releases or
threatened releases of chemicals, pollutants, contaminants, or toxic or
hazardous substances or wastes (collectively, "HAZARDOUS MATERIALS") into the
environment, or otherwise relating to the manufacture, processing, distribution,
use, treatment, storage, disposal, transport or handling of Hazardous Materials,
as well as all authorizations, codes, decrees, demands or demand letters,
injunctions, judgments, licenses, notices or notice letters, orders, permits,
plans or regulations issued, entered, promulgated or approved thereunder.

                  (ii)     Other than those that are or were stored, used or
disposed of in compliance with applicable law, to the knowledge of the Company,
no Hazardous Materials are contained on or about any real property currently
owned, leased or used by the Company or any of its Subsidiaries, and no
Hazardous Materials were released on or about any real property previously
owned, leased or used by the Company or any of its subsidiaries during the
period the property was owned, leased or used by the Company or any of its
subsidiaries.

                  (iii)    To the knowledge of the Company, there are no
underground storage tanks on or under any real property owned, leased or used by
the Company or any of its subsidiaries that are not in compliance with
applicable law.

                           o.       TITLE. The Company and its subsidiaries have
good and marketable title in fee simple to all real property and good and
marketable title to all personal property owned by them which is material to the
business of the Company and its subsidiaries, in each case free and clear of all
liens, encumbrances and defects except such as are described in Schedule 3(o) or
such as do not materially affect the value of such property and do not interfere
with the use made and proposed to be made of such

                                      -12-
<PAGE>

property by the Company and its subsidiaries. Any real property and facilities
held under lease by the Company and its subsidiaries are held by them under
valid, subsisting and enforceable leases with such exceptions as are not
material and do not interfere with the use made and proposed to be made of such
property and buildings by the Company and its subsidiaries.

                           p.       INSURANCE. The Company and each of its
subsidiaries are insured by insurers of recognized financial responsibility
against such losses and risks and in such amounts as is prudent and customary in
the businesses in which the Company and its subsidiaries are engaged. Neither
the Company nor any such subsidiary has any reason to believe that it will not
be able to renew its existing insurance coverage as and when such coverage
expires or to obtain similar coverage from similar insurers as may be necessary
to continue its business at a cost that would not individually or in the
aggregate have a Material Adverse Effect.

                           q.       REGULATORY PERMITS; COMPLIANCE. The Company
and its subsidiaries possess all franchises, grants, authorizations, licenses
permits, easements, consents, certificates, approvals and orders necessary to
own, lease and operate its properties and to conduct their respective businesses
as currently being conducted (collectively, the "COMPANY PERMITS"). There is no
action pending, or to the knowledge of the Company, threatened regarding the
suspension or cancellation of any of the Company Permits. Neither the Company
nor any of its subsidiaries is in conflict with, or in default or violation of,
any of the Company Permits except where such violation would not in the
aggregate have a Material Adverse Effect. Neither the Company nor any of its
subsidiaries has received any notification with respect to possible conflicts,
defaults, or violations of applicable laws.

                           r.       INTERNAL ACCOUNTING CONTROLS. The Company
and each of its subsidiaries maintain a system of internal accounting controls
sufficient to provide reasonable assurance that (i) transactions are executed in
accordance with management's general or specific authorizations, (ii)
transactions are recorded as necessary to permit preparation of financial
statements in conformity with generally accepted accounting principles and to
maintain asset accountability, (iii) access to assets is permitted only in
accordance with management's general or specific authorization and (iv) the
recorded accountability for assets is compared with the existing assets at
reasonable intervals and appropriate action is taken with respect to any
differences.

                           s.       NO MATERIALLY ADVERSE CONTRACTS, ETC.
Neither the Company nor any of its subsidiaries is subject to any charter,
corporate or other legal restriction, or any judgment, decree, order, rule or
regulation which has or is expected in the future individually or in the
aggregate to have a Material Adverse Effect. Neither the Company nor any of its
subsidiaries is a party to any contract or agreement which has or is expected to
have a Material Adverse Effect.

                           t.       TAX STATUS. Except as set forth on Schedule
3(t), the Company and each of its subsidiaries has made or filed all federal,
state and foreign income and all other tax returns, reports and declarations
required by any jurisdiction to

                                      -13-
<PAGE>

which it is subject (unless and only to the extent that the Company and each of
its subsidiaries has set aside on its books provisions reasonably adequate for
the payment of all unpaid and unreported taxes) and has paid all taxes and other
governmental assessments and charges shown or determined to be due on such
returns, reports and declarations, except those being contested in good faith
and has set aside on its books provision reasonably adequate for the payment of
all taxes for periods subsequent to the periods to which such returns, reports
or declarations apply. Except as set for on Schedule 3(t), there are no unpaid
taxes in any material amount claimed to be due by the taxing authority of any
jurisdiction, and the officers of the Company know of no basis for any such
claim. The Company has not executed a waiver with respect to the statute of
limitations relating to the assessment or collection of any foreign, federal,
state or local tax. The Company has not been notified that any of its tax
returns is currently being audited by any taxing authority.

                           u.       CERTAIN TRANSACTIONS. Except as set forth on
Schedule 3(u) or disclosed in the SEC Documents and except for arm's length
transactions pursuant to which the Company makes payments in the ordinary course
of business upon terms no less favorable than the Company could obtain from
third parties and other than the grant of stock options disclosed on Schedule
3(c), none of the officers, directors or employees of the Company or any of its
subsidiaries is presently a party to any transaction with the Company or any
subsidiary (other than for services as employees, officers and directors),
including any contract, agreement or other arrangement providing for the
furnishing of services to or by, providing for rental of real or personal
property to or from, or otherwise requiring payments to or from any officer,
director or such employee or, to the knowledge of the Company, any corporation,
partnership, trust or other entity in which any officer, director or any such
employee has a substantial interest or is an officer, director, trustee or
partner.

                           v.       S-3 REGISTRATION. The Company is currently
eligible to register secondary offerings of securities, including the resale of
Conversion Shares, the Warrant Shares and the Dividend Shares, on a registration
statement on Form S-3 under the 1933 Act.

                           w.       DISCLOSURE. All information relating to or
concerning the Company or any of its subsidiaries set forth in this Agreement
and provided to the Buyer pursuant to Section 2(d) hereof and otherwise in
connection with the transactions contemplated hereby is true and correct in all
material respects and the Company has not omitted to state any material fact
necessary in order to make the statements made herein or therein, in light of
the circumstances under which they were made, not misleading. No event or
circumstance has occurred or information exists with respect to the Company or
any of its subsidiaries or its or their business, properties, operations or
financial conditions, which, under applicable law, rule or regulation, requires
public disclosure or announcement by the Company but which has not been so
publicly announced or disclosed (assuming for this purpose that the Company's
reports filed under the 1934 Act are being incorporated into an effective
registration statement filed by the Company under the 1933 Act).

                                      -14-
<PAGE>

                           x.       INVESTMENT COMPANY STATUS. The Company is
not and upon consummation of the sale of the Securities will not be an
"investment company," a company controlled by an "investment company" or an
"affiliated person" of, or "promoter" or "principal underwriter" for, an
"investment company" as such terms are defined in the Investment Company Act of
1940, as amended.

                           y.       FOREIGN CORRUPT PRACTICES. Neither the
Company nor any of its subsidiaries, nor any director, officer, agent, employee
or other person acting on behalf of the Company or any subsidiary has, in the
course of his actions for, or on behalf of, the Company or any subsidiary used
any corporate funds for any unlawful contribution, gift, entertainment or other
unlawful expenses relating to political activity; made any direct or indirect
unlawful payment to any foreign or domestic government official or employee from
corporate funds; violated or is in violation of any provision of the U.S.
Foreign Corrupt Practices Act of 1977; or made any bribe, rebate, payoff,
influence payment, kickback or other unlawful payment to any foreign or domestic
government official or employee.

                           z.       SOLVENCY. The Company individually and
together with its subsidiaries on a consolidated basis (both before and after
giving effect to the transactions contemplated by this Agreement) is solvent
(i.e., its assets have a fair market value in excess of the amount required to
pay its probable liabilities on its existing debts as they become absolute and
matured) and currently the Company has no information that would lead it to
reasonably conclude that the Company would not have, nor does it intend to take
any action that would impair, its ability to pay its debts from time to time
incurred in connection therewith as such debts mature.

                  4.       COVENANTS AND AGREEMENTS.

                           a.       BEST EFFORTS. Each party shall use its best
efforts timely to satisfy each of the conditions to be satisfied by it as
provided in Sections 6 and 7 of this Agreement.

                           b.       FORM D. The Company agrees to file a Form D
with respect to the Securities as required under Regulation D and to provide a
copy thereof to each Buyer promptly after such filing. The Company shall, on or
before the Closing Date, take such action as the Company shall reasonably
determine is necessary to qualify the Securities for, or obtain exemption for
the Securities for, sale to the Buyers at the Closing pursuant to this Agreement
under applicable securities or "Blue Sky" laws of the states of the United
States, and shall provide evidence of any such action so taken to the Buyers on
or prior to the Closing Date.

                           c.       REPORTING STATUS. Until the earlier of (i)
six months after the date as of which the Investors (as that term is defined in
the Registration Rights Agreement) may sell all of the Conversion Shares, the
Dividend Shares and the Warrant Shares without restriction pursuant to Rule
144(k) promulgated under the 1933 Act (or successor thereto) or (ii) the date on
which (A) the Investors shall have sold all the Conversion Shares and the
Warrant Shares and (B) none of the Series D Preferred Shares

                                      -15-
<PAGE>

and Warrants are outstanding (the "REGISTRATION PERIOD"), the Company (x) shall
timely file all reports required to be filed with the SEC pursuant to the 1934
Act, and the Company shall not terminate its status as an issuer required to
file reports under the 1934 Act even if the 1934 Act or the rules and
regulations thereunder would otherwise permit such termination and (y) will use
its best efforts and take all necessary action to maintain its ability and
eligibility to register secondary offerings of securities on Form S-3.

                           d.       USE OF PROCEEDS. The Company will use the
proceeds from the sale of the Series D Preferred Shares and Warrants for working
capital and general corporate purposes and shall not otherwise, directly or
indirectly, use such proceeds for any loan to or investment in any other
corporation, partnership, enterprise or other person (except in connection with
its direct or indirect subsidiaries) or for the repurchase, redemption, or
retirement of any capital stock of the Company.

                           e.       FINANCIAL INFORMATION. The Company agrees to
file all reports, schedules, forms, statements and other documents required to
be filed by it with the SEC pursuant to the reporting requirements of the 1934
Act. The financial statements of the Company will be prepared in accordance with
generally accepted accounting principles, consistently applied except as stated
therein, and will fairly present in all material respects the consolidated
financial position of the Company and its consolidated subsidiaries and results
of their operations and cash flows for the periods then ended (subject, in the
case of unaudited statements, to omission of footnotes and normal year-end audit
adjustments). The Company agrees to send the following to each Investor (as that
term is defined in the Registration Rights Agreement) during the Registration
Period: (i) within five (5) days after the filing thereof with the SEC, a copy
of its Annual Reports on Form 10-K, its Quarterly Reports on Form 10-Q, any
Current Reports on Form 8-K and any registration statements or amendments filed
pursuant to the 1933 Act; (ii) within one (1) day after release thereof, copies
of all press releases issued by the Company or any of its subsidiaries; and
(iii) copies of any notices and other information made available or given to the
shareholders of the Company generally, contemporaneously with the making
available or giving thereof to the shareholders.

                           f.       RESERVATION OF SHARES. The Company shall
take all action necessary to at all times have authorized, and reserved for the
purpose of issuance, no less than 200% of the number of shares of Common Stock
necessary to provide for the issuance of (i) the Conversion Shares, (ii) the
Dividend Shares (calculated as of any date by dividing (x) $2,600,000 (less any
dividends paid prior to such date) by (y) 95% times the amount equal to the
average of the Closing Bid Prices (as defined in the Certificate of
Designations) for the ten trading days immediately preceding such date) and
(iii) the Warrant Shares, in accordance with the terms of this Agreement, the
Warrants and the Certificate of Designations; PROVIDED, FURTHER, that such
shares of Common Stock so reserved shall be allocated for issuance upon
conversion of Series D Preferred Stock pro rata among the Holders of Series D
Preferred Stock based on the number of Series D Preferred Stock held by such
Holder relative to the total number of outstanding Series D Preferred Stock.

                                      -16-
<PAGE>

                           g.       LISTING. The Company shall promptly secure
the listing of the Conversion Shares, the Dividend Shares, and Warrant Shares
upon the Nasdaq National Market ("NASDAQ") (subject to official notice of
issuance) and shall maintain, so long as any Buyer owns any of the Securities,
the listing of all Conversion Shares, Dividend Shares and Warrant Shares from
time to time issuable under the terms of this Agreement, the Certificate of
Designations and the Warrants on each national securities exchange and automated
quotation system, if any, upon which shares of Common Stock are then listed. The
Company shall promptly provide to each Buyer copies of any notices it receives
from NASDAQ regarding the continued eligibility of the Common Stock for listing
on NASDAQ or other principal exchange or quotation system on which the Common
Stock is listed or traded except to the extent that such notices would
constitute material non public information which, according to applicable law,
rule or regulation should have been disclosed publicly by the Company but which
has not been so disclosed as of such date. The Company shall pay all fees and
expenses in connection with satisfying its obligations under this Section 4(g).

                           h.       EXPENSES. Each of the Company and the Buyers
shall each pay its respective costs and expenses incurred by such party in
connection with the negotiation, investigation, preparation, execution, delivery
and performance of this Agreement and the agreements and documents referred to
herein; provided, that the Company shall reimburse the Buyers for the Buyers'
and its attorneys' fees and expenses incurred in connection with the preparation
of this Agreement and the agreements and documents referred to herein up to an
aggregate of $50,000. In addition to the foregoing, the Company agrees to pay on
demand all reasonable costs and expenses (including, without limitation,
reasonable fees and expenses of counsel to the Buyers) incurred by the Buyers in
connection with the enforcement of the Buyers' rights and/or the collection of
all amounts due under this Agreement and the agreements and documents referred
to herein.

                           i.       ADDITIONAL ISSUANCES OF SECURITIES.

                                    (i)      RIGHT OF FIRST REFUSAL. If at any
time on or before the one year anniversary of the Closing Date, the Company
shall desire to issue any Common Stock or other equity security or any other
security convertible, exchangeable or exercisable for Common Stock (including
any debt financing with an equity component) or any other right to acquire any
Common Stock (the "CONVERTIBLE SECURITIES") pursuant to Section 4(2) of the 1933
Act or an offering of equity securities (including any debt security with an
equity component) under Regulation D or Regulation S of the 1933 Act or in any
other private placement (other than (1) pursuant to Company authorized stock
option plans, (2) pursuant to Section 4(p) below), or (3) pursuant to a
Strategic Financing (as defined in the Certificate of Designations for Series D
Preferred Stock), then the Company shall first comply with the terms of this
Section 4(i).

                                    (ii)     NOTICE REQUIREMENTS. The Company
shall notify, or cause to be notified, the Buyers, by certified mail return
receipt requested, not less than five (5) business days prior to the time the
Company intends to consummate such

                                      -17-
<PAGE>

issuance (the "ISSUANCE NOTICE"). The Issuance Notice shall set forth all of the
terms of such proposed issuance.

                                    (iii)    EXERCISE OF RIGHT OF FIRST REFUSAL.
The right of first refusal provided for in this Section 4(i) may be exercised by
the Buyers by delivery of a written notice to the Company (the "EXERCISE
NOTICE"), within five (5) business days following receipt of the Issuance Notice
(the "REFUSAL PERIOD"). The Exercise Notice shall state that the Buyers agree to
purchase all and only all of the proposed issuance of such Common Stock or
Convertible Securities on terms set forth in the Issuance Notice.

                                    (iv)     RIGHT TO ISSUE SECURITIES. After
expiration of the Refusal Period, if the provisions of this Section 4(i) have
been complied with in all respects by the Company and no Exercise Notice has
been given, or if given, the Buyers have not agreed to purchase all of the
securities set forth in the Issuance Notice, the Company shall have the right
for forty-five (45) calendar days following the termination of the Refusal
Period to issue such securities, or any portion thereof not being purchased by
the Buyers, as the case may be, specified in the Issuance Notice on the terms
described in the Issuance Notice without further notice to the Buyers, but after
such forty-five (45) calendar days, no such issuance may be made without again
giving notice to the Buyers and complying with all of the requirements of this
Section 4(i).

                                    (v)      For so long as any Buyer
beneficially owns any Securities, the Company will not issue any Series D
Preferred Shares other than to the Buyers as contemplated hereby.

                           j.       DILUTIVE EFFECT. The Company understands and
acknowledges that the number of Conversion Shares and Warrant Shares issuable
upon conversion of the Series D Preferred Shares and exercise of the Warrants,
respectively, will increase in certain circumstances. The Company further
acknowledges and agrees that its obligation to issue Conversion Shares and
Warrant Shares upon conversion of the Series D Preferred Shares and exercise of
the Warrants, respectively, and to issue Dividend Shares in accordance with this
Agreement, the Certificate of Designations and the Warrants, as applicable, is
absolute and unconditional regardless of the dilutive effect that such issuance
may have on the ownership interests of other stockholders of the Company.

                           k.       DISCLOSURE. From and after the date hereof,
the Company will not provide to any Buyer any material non-public information
which, according to applicable law, rule or regulation should be disclosed
publicly by the Company but which has not been so disclosed.

                           l.       CORPORATE EXISTENCE. So long as any Buyer
beneficially owns any Series D Preferred Stock or Warrants, the Company shall
maintain its corporate existence in good standing under the laws of the
jurisdiction in which it is incorporated and shall not sell all or substantially
all of the Company's assets, except in the event of (i) a Major Transaction (as
defined in the Certificate of Designations) where the surviving or successor
entity in such transaction redeems all of the then outstanding shares of Series
D

                                      -18-
<PAGE>

Preferred Shares in accordance with and subject to the terms of the Certificate
of Designations, or (ii) a merger or consolidation or sale of all or
substantially all of the Company's assets for cash, or, if for securities, where
the surviving or successor entity in such transaction either (i) redeems all of
the then outstanding shares of Series D Preferred Shares in accordance with and
subject to the terms of the Certificate of Designations applicable to such
transactions, or (ii) (A) assumes the Company's obligations hereunder and under
the agreements and instruments entered into in connection herewith and (B) is a
publicly traded corporation whose common stock is listed for trading on the
American Stock Exchange, NASDAQ or the New York Stock Exchange. The parties
agree that a ClickShip Disposition (as defined in Section 4(p)(iii)) shall not
constitute a sale of all or substantially all of the Company's assets.

                           m.       COMPLIANCE WITH LAW. The Company will
conduct its business in compliance with all applicable laws, rules, ordinances
and regulations of the jurisdictions in which it is conducting business,
including, without limitation, all applicable local, state and federal
environmental laws and regulations except where the failure to comply with which
would have a Material Adverse Effect.

                           n.       INSURANCE. The Company shall maintain
liability, casualty and other insurance (subject to customary deductions and
retentions) with responsible insurance companies against such risk of the types
and in the amounts customarily maintained by companies of comparable size to the
Company.

                           o.       NO INTEGRATION. The Company will not conduct
any future offering that will be integrated with the issuance of the Securities
for purposes of the rules promulgated by the SEC or NASDAQ.

                           p.       SPIN OFF OF CLICKSHIP DIRECT, INC. (i) In
addition to any other rights set forth herein, in the event that the Company
distributes the shares or assets of ClickShip, to the shareholders of the
Company or consummates any similar transaction (the "CLICKSHIP DISTRIBUTION"),
concurrently with the date of such distribution, the Company shall issue to each
of the Buyers a ClickShip Warrant (in the form of EXHIBIT E attached hereto) to
purchase an amount of ClickShip's common stock equal to 125% of the number of
shares of ClickShip common stock and other securities and value that such Buyer
would be entitled to receive if such Buyer's shares of Series D Preferred Stock
were converted and such Buyer's Warrants were exercised as of the record date
for such distribution (the "CLICKSHIP WARRANTS"). While the Buyer should be
entitled to such ClickShip Warrants on the date of the ClickShip Distribution,
in order to accurately reflect the Purchase Price for such ClickShip Warrants,
unless the Buyers request otherwise, the Company and ClickShip may delay
physical delivery of such ClickShip Warrants until eleven (11) days after the
date of the ClickShip Distribution. In the event that the ClickShip Distribution
or the Clickship Disposition (as defined below) is not consummated by March 31,
2001, the Conversion Price then in effect shall be reduced, but not increased,
to an amount equal to the lesser of (1) the average of the Closing Bid Prices
for the twenty (20) trading days prior to such date and (2) 101% of the Closing
Bid Price of the trading day prior to such date. An equivalent adjustment shall
be made on

                                      -19-
<PAGE>

each subsequent September 30 and March 31 that the ClickShip Distribution or
ClickShip Disposition has not been consummated.

                                    (ii)     Following the ClickShip
Distribution, the Series D Preferred Shares shall remain the outstanding
obligations of the Company or its successor, and the Series D Preferred Stock
conversion price and the Warrant exercise price shall be reduced to reflect the
value of the ClickShip Distribution as more particularly set forth in the
Certificate of Designations and Warrants, respectively.

                                    (iii)    The Parties acknowledge and agree
that, provided that ClickShip is a wholly-owned subsidiary of the Company at
such time, the term "ClickShip Distribution" does not include a sale of all or
substantially all of the assets or stock of ClickShip to a third party or the
liquidation of the business and assets of ClickShip (the "CLICKSHIP
DISPOSITION"). In the event of a ClickShip Disposition, (A) the ClickShip
Registration Rights Agreement shall terminate, (B) there shall be no issuance of
the ClickShip Warrants as contemplated by Section 4(p)(i), and (C) there shall
be no adjustments contemplated by Section 4(p)(ii) above. In addition, the
parties agree that a ClickShip Disposition shall not constitute a Major
Transaction as defined in the Certificate of Designations.

                           q.       FILING OF FORM 8-K. On or before the second
(2nd) business day following the Closing Date the Company shall file a Current
Report on Form 8-K with the SEC describing the terms of the transactions
contemplated by this Agreement and including as exhibits to such Current Report
on Form 8-K this Agreement, the Certificate of Designations, the Registration
Rights Agreement and the Form of Warrant, in the form required by the 1934 Act.

                           r.       PUT RIGHT. The Company hereby agrees that in
the event that the Transfer Agent Instructions in the form attached to this
Agreement as EXHIBIT F are not executed by the Company's transfer agent on or
before October 20, 2000, then the Buyers shall have the right to put back their
Series D Preferred Stock to the Company and receive a return of their aggregate
$20 million investment, plus interest at the rate of 6.5%.

                  5.       TRANSFER AGENT INSTRUCTIONS.

                  The Company shall issue irrevocable instructions to its
transfer agent (in the form attached hereto as EXHIBIT F) to issue certificates,
or at a Buyer's request, to electronically issue such shares (e.g., through DWAC
or DTC) (such electronic issuance to be made only if such shares have been
registered under the 1933 Act), registered in the name of each Buyer or its
respective nominee(s), for the Conversion Shares, the Dividend Shares and the
Warrant Shares in such amounts as specified from time to time by each Buyer to
the Company in accordance with the terms of and upon conversion of the Series D
Preferred Shares and exercise of the Warrants, respectively (the "IRREVOCABLE
TRANSFER AGENT INSTRUCTIONS"). Prior to registration of the Conversion Shares,
the Dividend Shares and the Warrant Shares under the 1933 Act, such certificates
shall bear

                                      -20-
<PAGE>

the restrictive legend specified in Section 2(g) of this Agreement. The Company
warrants that no instruction with respect to the Securities other than (i) the
Irrevocable Transfer Agent Instructions referred to in first sentence of this
paragraph and (ii) stop transfer instructions to give effect to Section 2(f)
hereof (in the case of the Conversion Shares, the Dividend Shares and the
Warrant Shares, prior to registration of the Conversion Shares, the Dividend
Shares and the Warrant Shares under the 1933 Act), will be given by the Company
to its transfer agent and that the Securities shall otherwise be freely
transferable on the books and records of the Company as and to the extent
provided in this Agreement, the Registration Rights Agreement, the Certificate
of Designations and the Warrants. Nothing in this Section 5 shall affect in any
way each Buyer's obligations and agreement to comply with all applicable
securities laws upon resale of any of the Securities. If a Buyer provides the
Company with an opinion of counsel, in a generally acceptable form, that
registration of a resale by such Buyer of any of the Securities is not required
under the 1933 Act, the Company shall permit the transfer, and, in the case of
the Conversion Shares, the Dividend Shares or Warrant Shares, promptly instruct
its transfer agent to issue one or more certificates in such name and in such
denominations as specified by such Buyer. The Company acknowledges that a breach
by it of its obligations hereunder will cause irreparable harm to the Buyers by
vitiating the intent and purpose of the transaction contemplated hereby.
Accordingly, the Company acknowledges that the remedy at law for a breach of its
obligations under this Section 5 will be inadequate and agrees, in the event of
a breach or threatened breach by the Company of the provisions of this Section
5, that the Buyers shall be entitled, in addition to all other available
remedies, to an injunction restraining any breach and requiring immediate
issuance and transfer, without the necessity of showing economic loss and
without any bond or other security being required.

                  6.       CONDITIONS TO THE COMPANY'S OBLIGATION TO SELL.

                  The obligation of the Company hereunder to issue and sell the
Series D Preferred Shares and Warrants to each Buyer at the Closing is subject
to the satisfaction, with respect to each Buyer, at or before the Closing Date,
of each of the following conditions, provided that these conditions are for the
Company's sole benefit and may be waived by the Company at any time in its sole
discretion:

                           a.       Such Buyer shall have executed this
Agreement, the Registration Rights Agreement and the ClickShip Registration
Rights Agreement and delivered the same to the Company.

                           b.       Such Buyer shall have delivered to the
Company the purchase price for the Series D Preferred Shares being purchased by
such Buyer at the Closing by wire transfer of immediately available funds
pursuant to the wire instructions provided by the Company.

                           c.       The representations and warranties of such
Buyer shall be true and correct in all material respects as of the date when
made and as of the Closing Date as though made at that time (except for
representations and warranties that speak as of a specific date), and such Buyer
shall have performed, satisfied and complied in all

                                      -21-
<PAGE>

material respects with the covenants, agreements and conditions required by this
Agreement to be performed, satisfied or complied with by such Buyer at or prior
to the Closing Date.

                  7.       CONDITIONS TO EACH BUYER'S OBLIGATION TO PURCHASE.

                  The obligation of each Buyer hereunder to purchase the Series
D Preferred Shares and Warrants at the Closing is subject to the satisfaction,
at or before the Closing Date, of each of the following conditions, provided
that these conditions are for each Buyer's sole benefit and may be waived by
such Buyer at any time in its sole discretion:

                           a.       The Company shall have executed this
Agreement, the Registration Rights Agreement and the ClickShip Registration
Rights Agreement, and delivered the same to such Buyer.

                           b.       The Certificate of Designations shall have
been executed by the Company and filed with the Secretary of State of the State
of Minnesota, and a copy thereof certified by such Secretary shall have been
delivered to such Buyer.

                           c.       The Common Stock shall be listed and
authorized for trading on the Nasdaq National Market, and trading in the Common
Stock issuable upon conversion of the Series D Preferred Shares, exercise of the
Warrants and issuance of the Dividend Shares to be traded on the Nasdaq National
Market shall not have been suspended by the SEC or NASDAQ.

                           d.       The representations and warranties of the
Company shall be true and correct in all material respects (except to the extent
that any of such representations and warranties is already qualified as to
materiality in Section 3 above, in which case such representations and
warranties shall be true and correct without further qualification) as of the
date when made and as of the Closing Date as though made at that time (except
for individual representations and warranties that speak as of a specific date)
and the Company shall have performed, satisfied and complied in all material
respects with the covenants, agreements and conditions required by this
Agreement to be performed, satisfied or complied with by the Company at or prior
to the Closing Date. Such Buyer shall have received a certificate, executed by
the Chief Executive Officer or Chief Financial Officer of the Company, dated as
of the Closing Date, to the foregoing effect and as to such other matters as may
be reasonably requested by such Buyer including, without limitation, an update
as of the Closing Date regarding the representation contained in Section 3(c)
above.

                           e.       Each Buyer shall have received the opinion
of Kaplan Strangis & Kaplan, dated as of the Closing Date, in form, scope and
substance reasonably satisfactory to such Buyer and in substantially the form of
EXHIBIT G attached hereto.

                           f.       The Company shall have executed and
delivered to such Buyer the Stock Certificates (in such denominations as such
Buyer shall request) for the Series D Preferred Shares purchased by such Buyer
at the Closing.

                                      -22-
<PAGE>

                           g.       The Company shall have executed and
delivered to such Buyer the Warrants being purchased by such Buyer at the
Closing.

                           h.       The Board of Directors of the Company shall
have adopted the resolutions in substantially the form of EXHIBIT H attached
hereto.

                           i.       As of the Closing Date, the Company shall
have reserved out of its authorized and unissued Common Stock solely for the
purpose of effecting the conversion of the Series D Preferred Shares, the
issuance of Dividend Shares and the exercise of the Warrants, shares of Common
Stock to provide for the issuance of the Conversion Shares, the Dividend Shares
and Warrant Shares in accordance with the terms of this Agreement, the
Certificate of Designations and the Warrants.

                           j.       The Irrevocable Transfer Agent Instructions,
in the form of EXHIBIT F attached hereto, shall have been delivered to and
acknowledged in writing by the Company's transfer agent.

                           k.       The transactions contemplated hereby shall
not violate any law, regulation or order then in effect and applicable to Buyers
or the Company.

                  8.       INDEMNIFICATION. In consideration of each Buyer's
execution and delivery of this Agreement and acquiring the Securities hereunder
and in addition to all of the Company's other obligations under this Agreement,
the Company shall defend, protect, indemnify and hold harmless each Buyer and
each other holder of Securities and all of their officers, directors, employees
and agents (including, without limitation, those retained in connection with the
transactions contemplated by this Agreement) (collectively, the "BUYER
INDEMNITEES") from and against any and all actions, causes of action, suits,
claims, losses, costs, penalties, fees, liabilities and damages, and expenses in
connection therewith (irrespective of whether any such Buyer Indemnitee is a
party to the action for which indemnification hereunder is sought), and
including reasonable attorneys' fees and disbursements (the "BUYER INDEMNIFIED
LIABILITIES"), incurred by any Buyer Indemnitee (and shall advance the same) as
a result of, or arising out of, or relating to (a) subject to Section 9(i), any
misrepresentation or breach of any representation or warranty made by the
Company in this Agreement, the Certificate of Designations, the Warrants, the
Registration Rights Agreement or any other certificate, instrument or document
contemplated hereby or thereby, (b) any breach of any covenant, agreement or
obligation of the Company contained in this Agreement, the Certificate of
Designations, the Warrants or the Registration Rights Agreement or any other
certificate, instrument or document contemplated hereby or thereby, or (c)
unless such claims arise from a breach or default thereunder by the Buyer
Indemnitees, the execution, delivery, performance or enforcement of this
Agreement or any other instrument, document or agreement executed pursuant
hereto by any of the Buyer Indemnitees, any transaction financed or to be
financed in whole or in part, directly or indirectly, with the proceeds of the
issuance of the Series D Preferred Shares and Warrants. To the extent that the
foregoing undertaking by the Company may be unenforceable for any reason, the
Company shall make the maximum contribution to the payment and satisfaction of
each of the Buyer Indemnified Liabilities which is permissible under applicable
law.

                                      -23-
<PAGE>

                  9.       GOVERNING LAW; MISCELLANEOUS.

                           a.       GOVERNING LAW. This Agreement shall be
governed by and interpreted in accordance with the laws of the State of New York
without regard to the principles of conflict of laws.

                           b.       COUNTERPARTS. This Agreement may be executed
in two or more identical counterparts, all of which shall be considered one and
the same agreement and shall become effective when counterparts have been signed
by each and delivered to the other party; provided that a facsimile signature
shall be considered due execution and shall be binding upon the signatory
thereto with the same force and effect as if the signature were an original, not
a facsimile signature.

                           c.       HEADINGS. The headings of this Agreement are
for convenience of reference and shall not form part of, or affect the
interpretation of, this Agreement.

                           d.       SEVERABILITY. If any provision of this
Agreement shall be invalid or unenforceable in any jurisdiction, such invalidity
or unenforceability shall not affect the validity or enforceability of the
remainder of this Agreement in that jurisdiction or the validity or
enforceability of any provision of this Agreement in any other jurisdiction.

                           e.       ENTIRE AGREEMENT; AMENDMENTS. This Agreement
supersedes all other prior oral or written agreements between the Buyers, the
Company, their affiliates and persons acting on their behalf with respect to the
matters discussed herein, and this Agreement and the documents referenced herein
contain the entire understanding of the parties with respect to the matters
covered herein and therein and, except as specifically set forth herein or
therein, neither the Company nor any Buyer makes any representation, warranty,
covenant or undertaking with respect to such matters. No provision of this
Agreement may be waived or amended other than by an instrument in writing signed
by the party to be charged with enforcement.

                           f.       NOTICES. Any notices, consents, waivers or
other communications required or permitted to be given under the terms of this
Agreement shall be in writing and will be deemed to have been delivered (i) upon
receipt, when delivered personally; (ii) upon receipt, when sent by facsimile;
(iii) three days after being sent by U.S. certified mail, return receipt
requested, or (iv) one day after deposit with a nationally recognized overnight
delivery service, in each case properly addressed to the party to receive the
same. For purposes of consent under Section 4 (i)(ii), notice shall be delivered
only by U.S. certified mail, return receipt requested. The addresses and
facsimile numbers for such communications shall be:

                                      -24-
<PAGE>

                  if to the Company:
                           DAMARK International, Inc.
                           7101 Winnetka Avenue
                           Brooklyn Park, Minnesota 55428
                           Telephone:     763-531-0066
                           Facsimile:     763-531-0481
                           Attention:     Mark A. Cohn, Chairman and Chief
                           Executive Officer

                  with a copy to:
                           Kaplan, Stangis and Kaplan, P.A.
                           5500 Wells Fargo Center
                           90 South Seventh Street
                           Minneapolis, Minnesota 55402
                           Telephone:     612-375-1138
                           Facsimile:     612-375-1143

                           Attention:       Bruce J. Parker

                  If to the Transfer Agent:

                           Wells Fargo Shareowner Services
                           161 North Concord Exchange Street
                           South St. Paul, Minnesota 55075
                           Telephone:  800-468-9716
                           Facsimile:  651-450-4033

                           Attention: Shareowner Relations

                  If to a Buyer, to its address and facsimile number on the
                  Schedule of Buyers, with copies to such Buyer's counsel as set
                  forth on the Schedule of Buyers:

                  Each party shall provide five days' prior written notice to
the other party of any change in address or facsimile number.

                           g.       SUCCESSORS AND ASSIGNS. This Agreement shall
be binding upon and inure to the benefit of the parties and their respective
successors and assigns, including any purchasers of the Securities. The Company
shall not assign this Agreement or any rights or obligations hereunder without
the prior written consent of the Buyers. A Buyer may assign some or all of its
rights hereunder without the consent of the Company, provided, however, that any
such assignment shall not release such Buyer from its obligations hereunder
unless such obligations are assumed by such assignee.

                           h.       NO THIRD PARTY BENEFICIARIES. This Agreement
is intended for the benefit of the parties hereto and their respective permitted
successors and assigns,

                                      -25-
<PAGE>

and is not for the benefit of, nor may any provision hereof be enforced by, any
other person.

                           i.       SURVIVAL. The representations and warranties
of the Company and the Buyers contained in Sections 3 and 2, respectively, shall
survive the Closing until two years after the Closing Date. The agreements and
covenants set forth in Sections 4, 5 and 8, shall survive the Closing. Each
Buyer shall be responsible only for its own representations, warranties,
agreements and covenants hereunder.

                           j.       PUBLICITY. The Company and each Buyer shall
have the right to approve before issuance any press releases or any other public
statements with respect to the transactions contemplated hereby; PROVIDED,
HOWEVER, that the Company shall be entitled, without the prior approval of any
Buyer, to make any press release or other public disclosure with respect to such
transactions as is required by applicable law and regulations (although each
Buyer shall be consulted by the Company in connection with any such press
release or other public disclosure prior to its release and shall be provided
with a copy thereof), but only to the extent required by such law or regulation.

                           k.       FURTHER ASSURANCES. Each party shall do and
perform, or cause to be done and performed, all such further acts and things,
and shall execute and deliver all such other agreements, certificates,
instruments and documents, as the other party may reasonably request in order to
carry out the intent and accomplish the purposes of this Agreement and the
consummation of the transactions contemplated hereby.

                           l.       NO STRICT CONSTRUCTION. The language used in
this Agreement will be deemed to be the language chosen by the parties to
express their mutual intent, and no rules of strict construction will be applied
against any party.

                           m.       EQUITABLE RELIEF. The Company recognizes
that in the event that it fails to perform, observe, or discharge any or all of
its obligations under this Agreement, any remedy at law may prove to be
inadequate relief to the Buyers. The Company therefore agrees that the Buyers
shall be entitled to seek temporary and permanent injunctive relief in any such
case without the necessity of proving actual damages.

                           n.       CONSENT TO JURISDICTION. The parties hereto
expressly submit themselves to the exclusive jurisdiction of the state and
federal courts of New York in any action or proceeding relating to this
Agreement or any of the other documents contemplated hereby or any of the
transactions contemplated hereby or thereby. Each party hereby irrevocably
waives, to the fullest extent permitted by law, any objection that it may now or
hereafter have to the laying of venue of any such action, suit or proceeding
brought in such a court and any claim that any such action, suit or proceeding
brought in such a court has been brought in an inconvenient forum. The parties
hereto irrevocably and unconditionally consent to the service of process of any
of the aforementioned courts in any such action, suit or proceeding by the
mailing of copies thereof by registered or certified mail, postage prepaid, at
their respective addresses set forth or provided for herein, such service to
become effective 10 days after such mailing.

                                      -26-
<PAGE>

Nothing herein shall affect the right of any party to serve process in any
manner permitted by law or to commence legal proceedings or otherwise proceed
against the other parties in any other jurisdiction.

                                      -27-
<PAGE>

                  IN WITNESS WHEREOF, the Buyers and the Company have caused
this Securities Purchase Agreement to be duly executed as of the date first
written above.

                           COMPANY:

                           DAMARK INTERNATIONAL, INC.

                           By: ________________________________
                               Name: Mark A. Cohn
                               Title: Chairman and Chief Executive Officer

                           SUBSIDIARY

                           CLICKSHIP DIRECT, INC.
                           (With respect to Section 4(p) only)

                           By: ________________________________
                               Name: Mark A. Cohn
                               Title: Chairman and Chief Executive Officer

                           BUYERS:

                           BAYSTAR CAPITAL, L.P.,
                           a Delaware limited partnership

                           BY:      BayStar Capital Management LLC,
                                    Its General Partner

                                    By:___________________________
                                    Name:
                                    Title:

                                    1500 West Market Street, Suite 200
                                    Mequon, WI 53092
                                    Fax:  262-241-1888

                                      -28-
<PAGE>

                           BAYSTAR INTERNATIONAL LTD.,
                           a British Virgin Islands corporation

                           BY:      BayStar International Management LLC,
                                    Its Investment Manager

                                    By:___________________________
                                    Name:
                                    Title:

                                    1500 West Market Street, Suite 200
                                    Mequon, WI 53092
                                    Fax:  262-241-1888

                                    STARK INTERNATIONAL

                                    By:___________________________
                                       Name:
                                       Its:

                                       1500 West Market Street, Suite 200
                                       Mequon, WI 53092
                                       Fax:  262.241.1888

                                    SHEPHERD INVESTMENTS
                                      INTERNATIONAL, LTD.

                                    By:___________________________
                                       Name:
                                       Its:

                                       1500 West Market Street, Suite 200
                                       Mequon, WI 53092
                                       Fax:  262.241.1888

                                      -29-
<PAGE>

                               SCHEDULE OF BUYERS

<TABLE>
<CAPTION>
                                  Investor Address,         Principal Amount of
                                    Telephone and           Series D Preferred        Amount of      Investor's Advisor and Legal
         Investor Name             Facsimile Number               Shares              Warrants              Counsel Address
----------------------------  --------------------------  ------------------------  ---------------  ----------------------------
<S>                           <C>                          <C>                       <C>             <C>
BayStar Capital, L.P.         c/o BayStar Capital          60,000                    231,839         Eleazer Klein, Esq.
(Delaware)                    Management, LLC                                                        Schulte Roth & Zabel LLP
                              1500 West Market Street                                                900 Third Avenue
                              Mequon, Wisconsin  53092                                               New York, NY 10022
                                                                                                     Fax:  (212) 593-5955

BayStar International, Ltd.   c/o BayStar International    20,000                    77,281          Eleazer Klein, Esq.
(British Virgin Islands)      Management, LLC                                                        Schulte Roth & Zabel LLP
                              1500 West Market Street                                                900 Third Avenue
                              Mequon, Wisconsin  53092                                               New York, NY 10022
                                                                                                     Fax:  (212) 593-5955

Stark International           c/o Staro Asset Management   60,000                    231,839         Eleazer Klein, Esq.
(Bermuda)                     1500 West Market Street                                                Schulte Roth & Zabel LLP
                              Mequon, Wisconsin  53092                                               900 Third Avenue
                                                                                                     New York, NY 10022
                                                                                                     Fax:  (212) 593-5955

Shepherd Investments          c/o Staro Asset Management   60,000                 231,839            Eleazer Klein, Esq.
International, Ltd.           1500 West Market Street                                                Schulte Roth & Zabel LLP
(British Virgin Islands)      Mequon, Wisconsin  53092                                               900 Third Avenue
                              Fax:  (414) 241-1888                                                   New York, NY 10022
                                                                                                     Fax:  (212) 593-5955
</TABLE>

                                      -30-<PAGE>

                                                                    Exhibit 10.2

THIS WARRANT AND ANY SECURITIES ACQUIRED UPON EXERCISE OF THIS WARRANT HAVE NOT
BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE
SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED
OR ASSIGNED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR THE
SECURITIES UNDER SUCH ACT OR APPLICABLE STATE SECURITIES LAWS OR PURSUANT TO AN
APPLICABLE EXEMPTION TO THE REGISTRATION REQUIREMENTS OF SUCH ACT AND SUCH LAWS.

                           DAMARK INTERNATIONAL, INC.

                          COMMON STOCK PURCHASE WARRANT

No. [W-     ]                                                 September 29, 2000

                                                    Warrant to Purchase ________
                                                    Shares of Common Stock

                  DAMARK INTERNATIONAL, INC. a Minnesota corporation (the
"Company"), for value received, hereby certifies that [______] or registered
assigns (the "Holder"), is entitled to purchase from the Company [_________](1)
(the "Warrant Shares") duly authorized, validly issued, fully paid and
nonassessable shares of Class A Common Stock, par value $.01 per share, of the
Company (the "Common Stock"), at a purchase price equal to $16.17 per share (the
"Purchase Price"), at any time or from time to time on and after the date hereof
and prior to 5:00 P.M., New York City time, on September 29, 2003 (the
"Expiration Date"), all subject to the terms, conditions and adjustments set
forth below in this Warrant.

                  This Warrant is one of the Common Stock Purchase Warrants
(collectively, the "Warrants", such term to include any such warrants issued in
substitution therefor) originally issued pursuant to the terms of the Securities
Purchase Agreement, dated as of September 29, 2000, by and among the Company and
the Buyers signatory thereto (the "Purchase Agreement"). Capitalized terms used
herein and not otherwise defined herein shall have the meanings assigned such
terms in the Purchase Agreement.

----------------------------
(1)      Insert 50% of the number of the number of Conversion Shares assuming
full conversion on the Closing Date.

<PAGE>

                  1.       DEFINITIONS. As used herein, unless the context
otherwise requires, the following terms shall have the meanings indicated:

                  "ADDITIONAL SHARES OF COMMON STOCK" shall mean, all shares
(including treasury shares) of Common Stock issued or sold (or, pursuant to
Section 3.3 or 3.4, deemed to be issued) by the Company after September 29,
2000, whether or not subsequently reacquired or retired by the Company other
than (i) shares of Common Stock issued upon exercise of the Warrants, (ii) such
number of additional shares of Common Stock as may become issuable by exercise
of the Warrants by reason of adjustments required pursuant to the anti-dilution
provisions applicable to the Warrants, (iii) shares of Common Stock issued
pursuant to Approved Stock Plans, (iv) shares of Common Stock issued upon
conversion of the Series D Preferred Shares, (v) Dividend Shares, (vi) shares of
Common Stock issued pursuant to any right to purchase such shares in existence
as of August 31, 2000 and as set forth in Schedule 3(c) to the Purchase
agreement (the "Existing Options"), and (vii) shares of Common Stock issued in
connection with a Strategic Financing.

                  "ANNIVERSARY DATE" shall mean September 29 of each calendar
year.

                  "APPROVED STOCK PLAN" shall mean any contract, plan or
agreement which has been or shall be approved by the Board of Directors of the
Company or a committee of the Board of Directors, pursuant to which the
Company's securities may be issued to any employee, officer, director,
consultant or other service provider of the Company in an aggregate amount that
does not exceed 1,500,000 shares of Common Stock (subject to appropriate
adjustment for any stock dividends, any subdivision or combination, or other
reorganization of the outstanding shares of Common Stock).

                  "AVERAGE MARKET PRICE" shall mean the average of the Closing
Bid Prices of the Common Stock for the ten (10) trading days immediately
preceding the applicable date, except in the case of the issuance of shares of
Common Stock in an Underwritten Public Offering in which case the public
offering price to the public.

                  "BUSINESS DAY" shall mean any day other than a Saturday or a
Sunday or a day on which commercial banking institutions in the City of New York
are authorized by law to be closed. Any reference to "days" (unless Business
Days are specified) shall mean calendar days.

                  "BUY IN ACTUAL DAMAGES" shall have the meaning assigned to it
in Section 2.6 of this Agreement.

                  "CLOSING BID PRICE" shall mean for any security as of any
date, the closing bid price of such security on the principal securities
exchange or trade market where such security is listed or traded as reported by
Bloomberg, L.P. ("BLOOMBERG"), or if the foregoing does not apply, the closing
bid price of such security in the over-the-counter market on the electronic
bulletin board for such security as reported by Bloomberg, or, if no closing bid
price is reported for such security by Bloomberg, the average of the bid prices
of any market makers for such security as reported in the "pink sheets" by the

                                      -2-
<PAGE>

National Quotation Bureau, Inc. If the Closing Bid Price cannot be calculated
for such security on such date, as set forth above, the Closing Bid Price of
such security shall be the fair market value as determined in good faith by an
investment banking firm selected jointly by the Company and the Holders, with
the fees and expenses of such determination borne solely by the Company.

                  "COMMISSION" shall mean the Securities and Exchange Commission
or any successor agency having jurisdiction to enforce the Securities Act.

                  "COMMON STOCK" shall have the meaning assigned to it in the
introduction to this Warrant, such term to include any stock into which such
Common Stock shall have been changed or any stock resulting from any
reclassification of such Common Stock, and all other stock of any class or
classes (however designated) of the Company the holders of which have the right,
without limitation as to amount, either to all or to a share of the balance of
current dividends and liquidating dividends after the payment of dividends and
distributions on any shares entitled to preference.

                  "COMPANY" shall have the meaning assigned to it in the
introduction to this Warrant, such term to include any corporation or other
entity which shall succeed to or assume the obligations of the Company hereunder
in compliance with Section 4.

                  "CONVERTIBLE SECURITIES" shall mean any evidences of
indebtedness, shares of stock (other than Common Stock) or other securities
directly or indirectly convertible into or exchangeable for Additional Shares of
Common.

                  "CURRENT MARKET PRICE" shall mean, on any date specified
herein, the average of the daily Closing Bid Prices for the Common Stock during
the 10 consecutive trading days commencing 15 trading days before such date,
except that, if on any such date the shares of Common Stock are not listed or
admitted for trading on any national securities exchange or quoted in the
over-the-counter market, the Current Market Price shall be the Fair Value on
such date.

                  "DIVIDEND SHARES" shall mean the shares of Common Stock issued
in respect of dividends on the Series D Preferred Shares.

                  "EXCHANGE ACT" shall mean the Securities Exchange Act of 1934,
as amended from time to time, and the rules and regulations thereunder, or any
successor statute.

                  "EXPIRATION DATE" shall have the meaning assigned to it in the
introduction to this Warrant.

                  "FAIR VALUE" shall mean, on any date specified herein (i) in
the case of cash, the dollar amount thereof, (ii) in the case of a security
admitted for trading on any national securities exchange or quoted in the
over-the-counter market, the Current Market Price, and (iii) in all other cases
as determined in good faith jointly by the Board of Directors of the Company and
the Holder; PROVIDED, HOWEVER, that if such parties are unable to reach
agreement within a reasonable period of time, the Fair Value shall be

                                      -3-
<PAGE>

determined in good faith by an independent investment banking firm selected
jointly by the Company and the Holder or, if that selection cannot be made
within ten days, by an independent investment banking firm selected by the
American Arbitration Association in accordance with its rules, and PROVIDED
FURTHER, that the Company shall pay all of the fees and expenses of any third
parties incurred in connection with determining the Fair Value.

                  "OPTIONS" shall mean any rights, options or warrants to
subscribe for, purchase or otherwise acquire either Additional Shares of Common
Stock or Convertible Securities other than pursuant to the Existing Options and
the Options under an Approved Stock Plan.

                  "OTHER SECURITIES" shall mean any stock (other than Common
Stock) and other securities of the Company or any other Person (corporate or
otherwise) which the holders of the Warrants at any time shall be entitled to
receive, or shall have received, upon the exercise of the Warrants, in lieu of
or in addition to Common Stock, or which at any time shall be issuable or shall
have been issued in exchange for or in replacement of Common Stock or Other
Securities pursuant to Section 4 or otherwise.

                  "PERSON" shall mean any individual, firm, partnership,
corporation, trust, joint venture, association, joint stock company, limited
liability company, unincorporated organization or any other entity or
organization, including a government or agency or political subdivision thereof,
and shall include any successor (by merger or otherwise) of such entity.

                  "PURCHASE AGREEMENT" shall have the meaning assigned to it in
the introduction to this Warrant.

                  "PURCHASE PRICE" shall mean the amount per share indicated in
the introductory paragraph to this Warrant subject to adjustment and
readjustment from time to time as provided in Section 3, and, as so adjusted or
readjusted, shall remain in effect until a further adjustment or readjustment
thereof is required by Section 3.

                  "REGISTRATION RIGHTS AGREEMENT" shall mean the Registration
Agreement dated as of September 29, 2000, substantially in the form of Exhibit C
to the Purchase Agreement.

                  "RIGHTS" shall have the meaning assigned to it in Section
3.10.

                  "SECURITIES ACT" shall mean the Securities Act of 1933, as
amended from time to time, and the rules and regulations thereunder, or any
successor statute.

                  "STRATEGIC FINANCING" shall mean any future equity financing
whereby Common Stock or Convertible Securities are issued for consideration
other than cash or cash equivalents (e.g., notes) to any person or entity which
has or is proposed to have a material business, technology, lending, investment
or commercial relationship with the Company in addition to any equity financing
provided by such person or entity and it is determined by the Board of Directors
of the Company that such equity financing will

                                      -4-
<PAGE>

result in or further develop a material business, technology or commercial
relationship with the Company; PROVIDED, HOWEVER, that the aggregate number of
shares of Common Stock (including Convertible Securities and Options on a fully
diluted basis) that may be issued pursuant to Strategic Financings may not
exceed 750,000 shares.

                  "UNDERWRITTEN PUBLIC OFFERING" shall mean an offering of
shares of Common Stock through one or more investment banking firms that is
registered with the Commission in which the net proceeds received by the Company
exceeds $25 million.

                  "WARRANTS" shall have the meaning assigned to it in the
introduction to this Warrant.

                  2.       EXERCISE OF WARRANT.

                  2.1.     MANNER OF EXERCISE; PAYMENT OF THE PURCHASE PRICE.
(a) This Warrant may be exercised by the Holder, in whole or in part, at any
time or from time to time on and after the date hereof and prior to the
Expiration Date, by surrendering to the Company at its principal office (or such
other office or agency of the Company as the Company may designate in a written
notice to the Holder) this Warrant, together with the form of Election to
Purchase Shares attached hereto as Exhibit A (or a reasonable facsimile thereof)
duly executed by the Holder and accompanied by payment of the Purchase Price as
described below for the number of shares of Common Stock specified in such form.

                  (b)      Payment of the Purchase Price may be made as follows
(or by any combination of the following): (i) in United States currency by cash
or delivery of a certified check or bank draft payable to the order of the
Company or by wire transfer to the account of the Company, (ii) by cancellation
of such number of the shares of Common Stock otherwise issuable to the Holder
upon such exercise as shall be specified in such Election to Purchase Shares,
such that the excess of the Current Market Price of such specified number of
shares on the date of exercise over the portion of the Purchase Price
attributable to such shares shall equal the Purchase Price attributable to the
shares of Common Stock to be issued upon such exercise, in which case upon
delivery of such notice such amount shall be deemed to have been paid to the
Company and the number of shares issuable upon such exercise shall be reduced by
such specified number, or (iii) by surrender to the Company for cancellation,
certificates representing shares of Common Stock of the Company owned by the
Holder (properly endorsed for transfer in blank) having a Current Market Price
on the date of Warrant exercise equal to the Purchase Price.

                  2.2.     WHEN EXERCISE EFFECTIVE. Each exercise of this
Warrant shall be deemed to have been effected immediately prior to the close of
business on the Business Day on which this Warrant shall have been surrendered
to, and the Purchase Price shall have been received by, the Company as provided
in Section 2.1, and at such time the Person or Persons in whose name or names
any certificate or certificates for shares of Common Stock (or Other Securities)
shall be issuable upon such exercise as provided in

                                      -5-
<PAGE>

Section 2.3 shall be deemed to have become the holder or holders of record
thereof for all purposes.

                  2.3.     DELIVERY OF STOCK CERTIFICATES, ETC.; CHARGES, TAXES
AND EXPENSES. Subject to Section 2.5 (a) as soon as practicable after each
exercise of this Warrant, in whole or in part, and in any event within three
Business Days thereafter, the Company shall cause to be issued in such
denominations as may be requested by Holder in the Election to Purchase Shares,
in the name of and delivered to the Holder or, subject the Purchase Agreement,
as the Holder may direct,

                  (i)      a certificate or certificates, or, if then
         permissible under the Securities Act, at a Holder's request to
         electronically issue such shares (e.g., through DWAC or DTC), an
         electronic issuance for the number of shares of Common Stock (or Other
         Securities) to which the Holder shall be entitled upon such exercise
         plus, in lieu of issuance of any fractional share to which the Holder
         would otherwise be entitled, if any, a certified check for the amount
         of cash equal to the same fraction multiplied by the Current Market
         Price per share on the date of Warrant exercise, PROVIDED, HOWEVER,
         that in the event sufficient funds are not legally available for the
         payment of such amount, the number of shares of Common Stock for which
         such certificate(s) represents shall be rounded up to the nearest whole
         number, and

                  (ii)     in case such exercise is for less than all of the
         shares of Common Stock purchasable under this Warrant, a new Warrant or
         Warrants of like tenor, for the balance of the shares of Common Stock
         purchasable hereunder.

                  (b)      Issuance of certificates for shares of Common Stock
upon the exercise of this Warrant shall be made without charge to the Holder
hereof for any issue or transfer tax or other incidental expense, in respect of
the issuance of such certificates, all of which such taxes and expenses shall be
paid by the Company.

                  2.4.     COMPANY TO REAFFIRM OBLIGATIONS. The Company shall,
at the time of each exercise of this Warrant, upon the request of the Holder
hereof, acknowledge in writing its continuing obligation to afford to such
Holder all rights to which such Holder shall continue to be entitled after such
exercise in accordance with the terms of this Warrant, PROVIDED that if the
Holder of this Warrant shall fail to make any such request, such failure shall
not affect the continuing obligation of the Company to afford such rights to the
Holder.

                  2.5.     EXERCISE DISPUTES. In the case of any dispute with
respect to the number of shares to be issued upon exercise of this Warrant, the
Company shall promptly issue such number of shares of Common Stock that is not
disputed and shall submit the disputed determinations or arithmetic calculations
to the Holder via facsimile within two (2) Business Days of receipt of the
Holder's Election to Purchase Shares. If the Holder and the Company are unable
to agree as to the determination of the Purchase Price within two (2) Business
Days of such disputed determination or arithmetic calculation being submitted to
the Holder, then the Company shall in accordance with this Section, submit

                                      -6-
<PAGE>

via facsimile the disputed determination to an independent reputable accounting
firm of national standing, selected jointly by the Company and the Holder. The
Company shall cause such accounting firm to perform the determinations or
calculations and notify the Company and the Holder of the results within two (2)
business days from the time it receives the disputed determinations of
calculations. Such accounting firm's determination shall be binding upon all
parties absent manifest error. The Company shall then on the next Business Day
issue certificate(s) representing the appropriate number of shares of Common
Stock in accordance with such accounting firm's determination and this Section.
All fees and expenses of such determination and calculation shall be borne by
the Company.

                  2.6.     FAILURE TO DELIVER COMMON STOCK If, at any time, the
Holder of this Warrant submits this Warrant, an Election to Purchase Shares and
payment to the Company of the Purchase Price for each of the shares of Common
Stock specified in the Election to Purchase Shares in accordance with Section
2.1 above, and the Company, for any reason, fails to deliver, on or prior to the
last possible date which the Company could have issued such Common Stock to the
Holder without violating this Section 2, the number of shares of Common Stock
for which the Holder is entitled upon such exercise, the Company shall pay
damages to the Holder equal to the actual damages incurred by the Holder as a
result of the Holder's needing to "buy in" shares of Common Stock to the extent
necessary to satisfy its securities delivery requirements ("Buy In Actual
Damages")

                  3.       ADJUSTMENT OF COMMON STOCK ISSUABLE UPON EXERCISE.

                  3.1.     ADJUSTMENT OF NUMBER OF SHARES.

                           Upon each adjustment of the Purchase Price as a
result of the calculations made in this Section 3, this Warrant shall thereafter
evidence the right to receive, at the adjusted Purchase Price, that number of
shares of Common Stock (calculated to the nearest one-hundredth) obtained by
dividing (i) the product of the aggregate number of shares covered by this
Warrant immediately prior to such adjustment and the Purchase Price in effect
immediately prior to such adjustment of the Purchase Price by (ii) the Purchase
Price in effect immediately after such adjustment of the Purchase Price.

                  3.2.     ADJUSTMENT OF PURCHASE PRICE.

                  3.2.1.   ISSUANCE OF ADDITIONAL SHARES OF COMMON STOCK. In
case the Company at any time or from time to time after the date hereof shall
issue or sell Additional Shares of Common Stock (including Additional Shares of
Common Stock deemed to be issued pursuant to Section 3.3 or 3.4 but excluding
Additional Shares of Common Stock purchasable upon exercise of Rights referred
to in Section 3.10), without consideration or for a consideration per share less
than the Average Market Price as in effect immediately prior to such issue or
sale, then, and in each such case, subject to Section 3.8, the Purchase Price
shall be reduced, concurrently with such issue or sale, to a

                                      -7-
<PAGE>

price (calculated to the nearest .001 of a cent) determined by multiplying such
Purchase Price by a fraction

                  (a)      the numerator of which shall be the sum of (i) the
         number of shares of Common Stock outstanding immediately prior to such
         issue or sale and (ii) the number of shares of Common Stock which the
         gross consideration received by the Company for the total number of
         such Additional Shares of Common Stock so issued or sold would purchase
         at such Current Market Price, and

                  (b)      the denominator of which shall be the number of
         shares of Common Stock outstanding immediately after such issue or
         sale, PROVIDED that, for the purposes of this Section 3.2.1, (x)
         immediately after any Additional Shares of Common Stock are deemed to
         have been issued pursuant to Section 3.3 or 3.4, such Additional Shares
         shall be deemed to be outstanding, and (y) treasury shares shall not be
         deemed to be outstanding.

                  3.2.2.   EXTRAORDINARY DIVIDENDS AND DISTRIBUTIONS. In case
the Company at any time or from time to time after the date hereof shall
declare, order, pay or make a dividend or other distribution (including, without
limitation, any distribution of other or additional stock or other securities or
property or Options by way of dividend or spin-off, reclassification,
recapitalization or similar corporate rearrangement) on the Common Stock, other
than the ClickShip Distribution (as defined in Section 3.11), then, in each such
case, subject to Section 3.8, the Purchase Price in effect immediately prior to
the close of business on the record date fixed for the determination of holders
of any class of securities entitled to receive such dividend or distribution
shall be reduced, effective as of the close of business on such record date, to
a price determined by multiplying such Purchase Price by a fraction

                  (x)      the numerator of which shall be the Current Market
         Price in effect on such record date or, if the Common Stock trades on
         an ex-dividend basis, on the date prior to the commencement of
         ex-dividend trading, less the Fair Value of such dividend or
         distribution applicable to one share of Common Stock, and

                  (y)      the denominator of which shall be such Current Market
         Price.

                  3.3.     TREATMENT OF OPTIONS AND CONVERTIBLE SECURITIES. In
case the Company at any time or from time to time after the date hereof shall
issue, sell, grant or assume, or shall fix a record date for the determination
of holders of any class of securities of the Company entitled to receive, any
Options or Convertible Securities (whether or not the rights thereunder are
immediately exercisable) then, and in each such case, the maximum number of
Additional Shares of Common Stock (as set forth in the instrument relating
thereto, without regard to any provisions contained therein for a subsequent
adjustment of such number) issuable upon the exercise of such Options or, in the
case of Convertible Securities and Options therefor, the conversion or exchange
of such Convertible Securities, shall be deemed to be Additional Shares of
Common Stock issued as of the time of such issue, sale, grant or assumption or,
in case such a record date shall have been fixed, as of the close of business on
such record date (or, if the Common

                                      -8-
<PAGE>

Stock trades on an ex-dividend basis, on the date prior to the commencement of
ex-dividend trading), PROVIDED that such Additional Shares of Common Stock shall
not be deemed to have been issued unless (i) the consideration per share
(determined pursuant to Section 3.5) of such shares would be less than the
Average Market Price as in effect on the date of and immediately prior to such
issue, sale, grant or assumption or immediately prior to the close of business
on such record date (or, if the Common Stock trades on an ex-dividend basis, on
the date prior to the commencement of ex-dividend trading), as the case may be
and (ii) such Additional Shares of Common Stock are not purchasable pursuant to
Rights referred to in Section 3.10, and PROVIDED, FURTHER, that

                  (a)      whether or not the Additional Shares of Common Stock
         underlying such Options or Convertible Securities are deemed to be
         issued, no further adjustment of the Purchase Price shall be made upon
         the subsequent issue or sale of Convertible Securities or shares of
         Common Stock upon the exercise of such Options or the conversion or
         exchange of such Convertible Securities;

                  (b)      if such Options or Convertible Securities by their
         terms provide, with the passage of time or otherwise, for any increase
         in the consideration payable to the Company, or decrease in the number
         of Additional Shares of Common Stock issuable, upon the exercise,
         conversion or exchange thereof (by change of rate or otherwise), the
         Purchase Price computed upon the original issue, sale, grant or
         assumption thereof (or upon the occurrence of the record date, or date
         prior to the commencement of ex-dividend trading, as the case may be,
         with respect thereto), and any subsequent adjustments based thereon,
         shall, upon any such increase or decrease becoming effective, be
         recomputed to reflect such increase or decrease insofar as it affects
         such Options, or the rights of conversion or exchange under such
         Convertible Securities, which are outstanding at such time;

                  (c)      upon the expiration or termination (or purchase by
         the Company and cancellation or retirement) of any such Options which
         shall not have been exercised or the expiration of any rights of
         conversion or exchange under any such Convertible Securities which (or
         purchase by the Company and cancellation or retirement of any such
         Convertible Securities the rights of conversion or exchange under
         which) shall not have been exercised, the Purchase Price computed upon
         the original issue, sale, grant or assumption thereof (or upon the
         occurrence of the record date, or date prior to the commencement of
         ex-dividend trading, as the case may be, with respect thereto), and any
         subsequent adjustments based thereon, shall, upon such expiration (or
         such cancellation or retirement, as the case may be), be recomputed as
         if:

                           (i)      in the case of Options for Common Stock or
                  Convertible Securities, the only Additional Shares of Common
                  Stock issued or sold were the Additional Shares of Common
                  Stock, if any, actually issued or sold upon the exercise of
                  such Options or the conversion or exchange of such Convertible
                  Securities and the consideration received therefor was the
                  consideration actually received by the Company for the issue,
                  sale,

                                      -9-
<PAGE>

                  grant or assumption of all such Options, whether or not
                  exercised, plus the consideration actually received by the
                  Company upon such exercise, or for the issue or sale of all
                  such Convertible Securities which were actually converted or
                  exchanged, plus the additional consideration, if any, actually
                  received by the Company upon such conversion or exchange, and

                           (ii)     in the case of Options for Convertible
                  Securities, only the Convertible Securities, if any, actually
                  issued or sold upon the exercise of such Options were issued
                  at the time of the issue or sale, grant or assumption of such
                  Options, and the consideration received by the Company for the
                  Additional Shares of Common Stock deemed to have then been
                  issued was the consideration actually received by the Company
                  for the issue, sale, grant or assumption of all such Options,
                  whether or not exercised, plus the consideration deemed to
                  have been received by the Company (pursuant to Section 3.5)
                  upon the issue or sale of such Convertible Securities with
                  respect to which such Options were actually exercised;

                  (d)      no readjustment pursuant to subdivision (b) or (c)
         above shall have the effect of increasing the Purchase Price by an
         amount in excess of the amount of the adjustment thereof originally
         made in respect of the issue, sale, grant or assumption of such Options
         or Convertible Securities; and

                  (e)      in the case of any such Options which expire by their
         terms not more than 30 days after the date of issue, sale, grant or
         assumption thereof, no adjustment of the Purchase Price shall be made
         until the expiration or exercise of all such Options, whereupon such
         adjustment shall be made in the manner provided in subdivision (c)
         above.

                  3.4.     TREATMENT OF STOCK DIVIDENDS, STOCK SPLITS, ETC. In
case the Company at any time or from time to time after the date hereof shall
declare or pay any dividend on the Common Stock payable in Common Stock, or
shall effect a subdivision of the outstanding shares of Common Stock into a
greater number of shares of Common Stock (by reclassification or otherwise than
by payment of a dividend in Common Stock), then, and in each such case,
Additional Shares of Common Stock shall be deemed to have been issued (a) in the
case of any such dividend, immediately after the close of business on the record
date for the determination of holders of any class of securities entitled to
receive such dividend, or (b) in the case of any such subdivision, at the close
of business on the day immediately prior to the day upon which such corporate
action becomes effective.

                  3.5.     COMPUTATION OF CONSIDERATION. For the purposes of
this Section 3,

                  (a)      the consideration for the issue or sale of any
         Additional Shares of Common Stock shall, irrespective of the accounting
         treatment of such consideration,

                                      -10-
<PAGE>

                           (i)      insofar as it consists of cash, be computed
                  at the amount of cash received by the Company, without
                  deducting any expenses paid or incurred by the Company or any
                  commissions or compensations paid or concessions or discounts
                  allowed to underwriters, dealers or others performing similar
                  services in connection with such issue or sale,

                           (ii)     insofar as it consists of property
                  (including securities) other than cash, be computed at the
                  Fair Value thereof at the time of such issue or sale, and

                           (iii)    in case Additional Shares of Common Stock
                  are issued or sold together with other stock or securities or
                  other assets of the Company for a consideration which covers
                  both, be the portion of such consideration so received,
                  computed as provided in clauses (i) and (ii) above, allocable
                  to such Additional Shares of Common Stock, such allocation to
                  be determined in the same manner that the Fair Value of
                  property not consisting of cash or securities is to be
                  determined as provided in the definition of 'Fair Value'
                  herein;

                  (b)      Additional Shares of Common Stock deemed to have been
         issued pursuant to Section 3.3, relating to Options and Convertible
         Securities, shall be deemed to have been issued for a consideration per
         share determined by dividing

                           (i)      the total amount, if any, received and
                  receivable by the Company as consideration for the issue,
                  sale, grant or assumption of the Options or Convertible
                  Securities in question, plus the minimum aggregate amount of
                  additional consideration (as set forth in the instruments
                  relating thereto, without regard to any provision contained
                  therein for a subsequent adjustment of such consideration to
                  protect against dilution) payable to the Company upon the
                  exercise in full of such Options or the conversion or exchange
                  of such Convertible Securities or, in the case of Options for
                  Convertible Securities, the exercise of such Options for
                  Convertible Securities and the conversion or exchange of such
                  Convertible Securities, in each case computing such
                  consideration as provided in the foregoing subdivision (a),

                  by

                           (ii)     the maximum number of shares of Common Stock
                  (as set forth in the instruments relating thereto, without
                  regard to any provision contained therein for a subsequent
                  adjustment of such number to protect against dilution)
                  issuable upon the exercise of such Options or the conversion
                  or exchange of such Convertible Securities; and

                  (c)      Additional Shares of Common Stock deemed to have been
         issued pursuant to Section 3.4, relating to stock dividends, stock
         splits, etc., shall be deemed to have been issued for no consideration.

                                      -11-
<PAGE>

                  3.6.     ADJUSTMENTS FOR COMBINATIONS, ETC. In case the
outstanding shares of Common Stock shall be combined or consolidated, by
reclassification or otherwise, into a lesser number of shares of Common Stock,
the Purchase Price in effect immediately prior to such combination or
consolidation shall, concurrently with the effectiveness of such combination or
consolidation, be proportionately increased.

                  3.7.     DILUTION IN CASE OF OTHER SECURITIES. In case any
Other Securities shall be issued or sold or shall become subject to issue or
sale upon the conversion or exchange of any stock (or Other Securities) of the
Company (or any issuer of Other Securities or any other Person referred to in
Section 4) or to subscription, purchase or other acquisition pursuant to any
Options issued or granted by the Company (or any such other issuer or Person)
for a consideration such as to dilute, on a basis consistent with the standards
established in the other provisions of this Section 3, the purchase rights
granted by this Warrant, then, and in each such case, the computations,
adjustments and readjustments provided for in this Section 3 with respect to the
Purchase Price and the number of shares purchasable upon Warrant exercise shall
be made as nearly as possible in the manner so provided and applied to determine
the amount of Other Securities from time to time receivable upon the exercise of
the Warrants, so as to protect the holders of the Warrants against the effect of
such dilution.

                  3.8.     DE MINIMIS ADJUSTMENTS. If the amount of any
adjustment of the Purchase Price per share required pursuant to this Section 3
would be less than $.01, such amount shall be carried forward and adjustment
with respect thereto made at the time of and together with any subsequent
adjustment which, together with such amount and any other amount or amounts so
carried forward, shall aggregate a change in the Purchase Price of at least $.01
per share. All calculations under this Warrant shall be made to the nearest .001
of a cent or to the nearest one-hundredth of a share, as the case may be.

                  3.9.     ABANDONED DIVIDEND OR DISTRIBUTION. If the Company
shall take a record of the holders of its Common Stock for the purpose of
entitling them to receive a dividend or other distribution (which results in an
adjustment to the Purchase Price under the terms of this Warrant) and shall,
thereafter, and before such dividend or distribution is paid or delivered to
stockholders entitled thereto, legally abandon its plan to pay or deliver such
dividend or distribution, then any adjustment made to the Purchase Price and
number of shares of Common Stock purchasable upon Warrant exercise by reason of
the taking of such record shall be reversed, and any subsequent adjustments,
based thereon, shall be recomputed.

                  3.10.    SHAREHOLDER RIGHTS PLAN. Notwithstanding the
foregoing, in the event that the Company shall distribute "poison pill" rights
pursuant to a "poison pill" shareholder rights plan (the "Rights"), the Company
shall, in lieu of making any adjustment pursuant to Section 3.2.1 or Section
3.2.2 hereof, make proper provision so that each Holder who exercises a Warrant
after the record date for such distribution and prior to the expiration or
redemption of the Rights shall be entitled to receive upon such exercise, in
addition to the shares of Common Stock issuable upon such exercise, a number of
Rights to be determined as follows: (i) if such exercise occurs on or prior to
the date for the distribution to the holders of Rights of separate certificates
evidencing

                                      -12-
<PAGE>

such Rights (the "Distribution Date"), the same number of Rights to which a
holder of a number of shares of Common Stock equal to the number of shares of
Common Stock issuable upon such exercise at the time of such exercise would be
entitled in accordance with the terms and provisions of and applicable to the
Rights; and (ii) if such exercise occurs after the Distribution Date, the same
number of Rights to which a holder of the number of shares into which the
Warrant so exercised was exercisable immediately prior to the Distribution Date
would have been entitled on the Distribution Date in accordance with the terms
and provisions of and applicable to the Rights, and in each case subject to the
terms and conditions of the Rights.

                           3.11.    CLICKSHIP DIRECT DISTRIBUTION. In addition
to any other rights set forth herein, in the event that the Company distributes
the shares or assets of ClickShip Direct, Inc. ("ClickShip"), to the
shareholders of the Company or consummates any similar transaction (the
"ClickShip Distribution"), the Warrants shall remain the outstanding obligations
of the Company or its successor and the Purchase Price then in effect shall be
reduced by an amount equal to the greater of (i) the average of the Closing Bid
Prices of the principal securities of ClickShip that trade on the principal
exchange or market for such securities for the ten (10) trading days immediately
following the date of the ClickShip Distribution, (ii) the value per share to
the shareholders of the Company established by the Board for federal income tax
purposes as a result of the ClickShip Distribution and (iii) the difference
between (x) the average Closing Bid Prices of the Common Stock for the ten (10)
trading days ending on the trading day immediately preceding the date of the
ClickShip Distribution and (y) the average of the Closing Bid Prices for the ten
(10) trading days immediately following the date of the ClickShip Distribution.
In the event that the ClickShip Distribution or the ClickShip Disposition (as
defined in the Purchase Agreement) is not consummated by March 31, 2001, the
Conversion Price then in effect shall be reduced, but not increased, to an
amount equal to the lesser of (1) the average of the Closing Bid Prices for the
twenty (20) trading days prior to such date and (2) 101% of the Closing Bid
Price of the trading day prior to such date. An equivalent adjustment shall be
made on each subsequent September 30 and March 31 that the ClickShip
Distribution or the ClickShip Disposition has not been consummated.

                  4.       CONSOLIDATION, MERGER, ETC.

                  4.1.     ADJUSTMENTS FOR CONSOLIDATION, MERGER, SALE OF
ASSETS, REORGANIZATION, ETC. In case the Company after the date hereof (a) shall
consolidate with or merge into any other Person and shall not be the continuing
or surviving corporation of such consolidation or merger, or (b) shall permit
any other Person to consolidate with or merge into the Company and the Company
shall be the continuing or surviving Person but, in connection with such
consolidation or merger, the Common Stock or Other Securities shall be changed
into or exchanged for stock or other securities of any other Person or cash or
any other property, or (c) shall transfer all or substantially all of its
properties or assets to any other Person, or (d) shall effect a capital
reorganization or reclassification of the Common Stock or Other Securities
(other than a capital reorganization or reclassification resulting in the issue
of Additional Shares of Common Stock for which adjustment in the Purchase Price
is provided in Section 3.2.1 or 3.2.2),

                                      -13-
<PAGE>

then, and in the case of each such transaction, proper provision shall be made
so that, upon the basis and the terms and in the manner provided in this
Warrant, the Holder of this Warrant, upon the exercise hereof at any time after
the consummation of such transaction shall be entitled to receive (at the
aggregate Purchase Price in effect at the time of such consummation for all
Common Stock or Other Securities issuable upon such exercise immediately prior
to such consummation), in lieu of the Common Stock or Other Securities issuable
upon such exercise prior to such consummation, the amount of securities, cash or
other property to which such Holder would actually have been entitled as a
stockholder upon such consummation if such Holder had exercised this Warrant
immediately prior thereto, subject to adjustments (subsequent to such
consummation) as nearly equivalent as possible to the adjustments provided for
in Sections 3 through 5.

                  4.2.     ASSUMPTION OF OBLIGATIONS. Notwithstanding anything
contained in the Warrants or in the Purchase Agreement to the contrary, the
Company shall not effect any of the transactions described in clauses (a)
through (d) of Section 4.1 unless, prior to the consummation thereof, each
Person (other than the Company) which may be required to deliver any stock,
securities, cash or property upon the exercise of this Warrant as provided
herein shall assume, by written instrument delivered to, and reasonably
satisfactory to, the Holder of this Warrant, (a) the obligations of the Company
under this Warrant (and if the Company shall survive the consummation of such
transaction, such assumption shall be in addition to, and shall not release the
Company from, any continuing obligations of the Company under this Warrant), (b)
the obligations of the Company under the Purchase Agreement and the Registration
Rights Agreement and (c) the obligation to deliver to the Holder such shares of
stock, securities, cash or property as, in accordance with the foregoing
provisions of this Section 4, the Holder may be entitled to receive. Nothing in
this Section 4 shall be deemed to authorize the Company to enter into any
transaction not otherwise permitted by the Purchase Agreement.

                  5.       OTHER DILUTIVE EVENTS. In case any event shall occur
as to which the provisions of Section 3 or Section 4 hereof are not strictly
applicable or if strictly applicable would not fairly protect the purchase
rights of the Holder in accordance with the essential intent and principles of
such Sections, then, in each such case, the Board of Directors of the Company
shall make an adjustment in the application of such provisions, in accordance
with such essential intent and principles, so as to preserve, without dilution,
the purchase rights represented by this Warrant.

                  6.       NO DILUTION OR IMPAIRMENT. The Company shall not, by
amendment of its certificate of incorporation or through any consolidation,
merger, reorganization, transfer of assets, dissolution, issue or sale of
securities or any other voluntary action, avoid or seek to avoid the observance
or performance of any of the terms of this Warrant, but will at all times in
good faith assist in the carrying out of all such terms and in the taking of all
such action as may be reasonably necessary or appropriate in order to protect
the rights of the Holder of this Warrant against dilution or other impairment.
Without limiting the generality of the foregoing, the Company (a) shall not
permit the par value of any shares of stock receivable upon the exercise of this
Warrant to exceed the amount payable therefor upon such exercise, (b) shall take
all

                                      -14-
<PAGE>

such action as may be necessary or appropriate in order that the Company may
validly and legally issue fully paid and nonassessable shares of stock, free
from all taxes, liens, security interests, encumbrances, preemptive rights and
charges on the exercise of the Warrants from time to time outstanding, (c) shall
not take any action which results in any adjustment of the Purchase Price if the
total number of shares of Common Stock (or Other Securities) issuable after the
action upon the exercise of all of the Warrants would exceed the total number of
shares of Common Stock (or Other Securities) then authorized by the Company's
certificate of incorporation and available for the purpose of issue upon such
exercise, and (d) shall not issue any capital stock of any class which is
preferred as to dividends or as to the distribution of assets upon voluntary or
involuntary dissolution, liquidation or winding-up, unless the rights of the
holders thereof shall be limited to a fixed sum or percentage of par value or a
sum determined by reference to a formula based on a published index of interest
rates, an interest rate publicly announced by a financial institution or a
similar indicator of interest rates in respect of participation in dividends and
to a fixed sum or percentage of par value in any such distribution of assets.

                  7.       CERTIFICATE AS TO ADJUSTMENTS. In each case of any
adjustment or readjustment in the shares of Common Stock (or Other Securities)
issuable upon the exercise of this Warrant, the Company at its expense shall
promptly compute such adjustment or readjustment in accordance with the terms of
this Warrant and prepare a certificate, signed by the Chairman of the Board,
President or one of the Vice Presidents of the Company, and by the Chief
Financial Officer, the Treasurer or one of the Assistant Treasurers of the
Company, setting forth such adjustment or readjustment and showing in reasonable
detail the method of calculation thereof and the facts upon which such
adjustment or readjustment is based, including a statement of (a) the
consideration received or to be received by the Company for any Additional
Shares of Common Stock issued or sold or deemed to have been issued, (b) the
number of shares of Common Stock outstanding or deemed to be outstanding, and
(c) the Purchase Price in effect immediately prior to such issue or sale and as
adjusted and readjusted (if required by Section 3) on account thereof. The
Company shall forthwith mail a copy of each such certificate to each holder of a
Warrant and shall, upon the written request at any time of any holder of a
Warrant, furnish to such holder a like certificate. The Company shall also keep
copies of all such certificates at its principal office and shall cause the same
to be available for inspection at such office during normal business hours by
any holder of a Warrant or any prospective purchaser of a Warrant designated by
the holder thereof. The Company shall, upon the request in writing of the Holder
(at the Company's expense), retain independent public accountants of recognized
national standing selected by the Board of Directors of the Company to make any
computation required in connection with adjustments under this Warrant, and a
certificate signed by such firm shall be conclusive evidence of the correctness
of such adjustment, which shall be binding on the Holder and the Company.

                  8.       NOTICES OF CORPORATE ACTION. In the event of:

                  (a)      any taking by the Company of a record of the holders
         of any class of securities for the purpose of determining the holders
         thereof who are entitled to receive any dividend or other distribution,
         or any right to subscribe for, purchase

                                      -15-
<PAGE>

         or otherwise acquire any shares of stock of any class or any other
         securities or property, or to receive any other right, or

                  (b)      any capital reorganization of the Company, any
         reclassification or recapitalization of the capital stock of the
         Company, any consolidation or merger involving the Company and any
         other Person, any transaction or series of transactions in which more
         than 50% of the voting securities of the Company are transferred to
         another Person, or any transfer, sale or other disposition of all or
         substantially all the assets of the Company to any other Person, or

                  (c)      any voluntary or involuntary dissolution, liquidation
         or winding-up of the Company,

the Company shall mail to each holder of a Warrant a notice specifying (i) the
date or expected date on which any such record is to be taken for the purpose of
such dividend, distribution or right, and the amount and character of such
dividend, distribution or right, and (ii) the date or expected date on which any
such reorganization, reclassification, recapitalization, consolidation, merger,
transfer, sale, disposition, dissolution, liquidation or winding-up is to take
place and the time, if any such time is to be fixed, as of which the holders of
record of Common Stock (or Other Securities) shall be entitled to exchange their
shares of Common Stock (or Other Securities) for the securities or other
property deliverable upon such reorganization, reclassification,
recapitalization, consolidation, merger, transfer, dissolution, liquidation or
winding-up. Such notice shall be mailed at least 20 days prior to the date
therein specified but in no event earlier than the public announcement of such
proposed transaction or event.

                  9.       INTENTIONALLY OMITTED.

                  10.      RESERVATION OF STOCK, ETC. The Company shall at all
times reserve and keep available, solely for issuance and delivery upon exercise
of the Warrants, the number of shares of Common Stock (or Other Securities) from
time to time issuable upon exercise of all Warrants at the time outstanding and
otherwise in accordance with the terms of the Purchase Agreement. All shares of
Common Stock (or Other Securities) issuable upon exercise of any Warrants shall
be duly authorized and, when issued upon such exercise, shall be validly issued
and, in the case of shares, fully paid and nonassessable with no liability on
the part of the holders thereof, and, in the case of all securities, shall be
free from all taxes, liens, security interests, encumbrances, preemptive rights
and charges. The transfer agent for the Common Stock, which may be the Company
(the "Transfer Agent"), and every subsequent Transfer Agent for any shares of
the Company's capital stock issuable upon the exercise of any of the purchase
rights represented by this Warrant, are hereby irrevocably authorized and
directed at all times until the Expiration Date to reserve such number of
authorized and unissued shares as shall be requisite for such purpose. The
Company shall keep copies of this Warrant on file with the Transfer Agent for
the Common Stock and with every subsequent Transfer Agent for any shares of the
Company's capital stock issuable upon the exercise of the rights of purchase
represented by this Warrant. The Company shall supply such Transfer Agent with
duly executed stock certificates for such purpose. All Warrant Certificates

                                      -16-
<PAGE>

surrendered upon the exercise of the rights thereby evidenced shall be canceled,
and such canceled Warrants shall constitute sufficient evidence of the number of
shares of stock which have been issued upon the exercise of such Warrants.
Subsequent to the Expiration Date, no shares of stock need be reserved in
respect of any unexercised Warrant.

                  11.      REGISTRATION AND TRANSFER OF WARRANTS, ETC.

                  11.1.    WARRANT REGISTER; OWNERSHIP OF WARRANTS. Each Warrant
issued by the Company shall be numbered and shall be registered in a warrant
register (the "Warrant Register") as it is issued and transferred, which Warrant
Register shall be maintained by the Company at its principal office or, at the
Company's election and expense, by a Warrant Agent or the Company's transfer
agent. The Company shall be entitled to treat the registered Holder of any
Warrant on the Warrant Register as the owner in fact thereof for all purposes
and shall not be bound to recognize any equitable or other claim to or interest
in such Warrant on the part of any other Person, and shall not be affected by
any notice to the contrary, except that, if and when any Warrant is properly
assigned in blank, the Company may (but shall not be obligated to) treat the
bearer thereof as the owner of such Warrant for all purposes. A Warrant, if
properly assigned, may be exercised by a new holder without a new Warrant first
having been issued.

                  11.2.    TRANSFER OF WARRANTS. This Warrant and all rights
hereunder are transferable in whole or in part, without charge to the Holder
hereof, upon surrender of this Warrant with a properly executed Form of
Assignment attached hereto as Exhibit B at the principal office of the Company
(or such other office or agency of the Company as it may in writing designate to
the Holder). Upon any partial transfer, the Company shall at its expense issue
and deliver to the Holder a new Warrant of like tenor, in the name of the
Holder, which shall be exercisable for such number of shares of Common Stock
with respect to which rights under this Warrant were not so transferred and to
the transferee a new Warrant of like tenor, in the name of the transferee, which
shall be exercisable for such number of shares of Common Stock with respect to
which rights under this Warrant were so transferred.

                  11.3.    REPLACEMENT OF WARRANTS. On receipt by the Company of
evidence reasonably satisfactory to the Company of the loss, theft, destruction
or mutilation of this Warrant and, in the case of any such loss, theft or
destruction of this Warrant, on delivery of an indemnity agreement reasonably
satisfactory in form and amount to the Company or, in the case of any such
mutilation, on surrender of such Warrant to the Company at its principal office
and cancellation thereof, the Company at its expense shall execute and deliver,
in lieu thereof, a new Warrant of like tenor.

                  11.4.    ADJUSTMENTS TO PURCHASE PRICE AND NUMBER OF SHARES.
Notwithstanding any adjustment in the Purchase Price or in the number or kind of
shares of Common Stock purchasable upon exercise of this Warrant, any Warrant
theretofore or thereafter issued may continue to express the same number and
kind of shares of Common Stock as are stated in this Warrant, as initially
issued.

                                      -17-
<PAGE>

                  11.5.    FRACTIONAL SHARES. Notwithstanding any adjustment
pursuant to Section 3 in the number of shares of Common Stock covered by this
Warrant or any other provision of this Warrant, the Company shall not be
required to issue fractions of shares upon exercise of this Warrant or to
distribute certificates which evidence fractional shares. In lieu of fractional
shares, the Company shall make payment to the Holder, at the time of exercise of
this Warrant as herein provided, in an amount in cash equal to such fraction
multiplied by the Current Market Price of a share of Common Stock on the date of
Warrant exercise.

                  12.      REDEMPTION The Company at any time after a Redemption
Event, upon thirty (30) days prior written notice delivered to the Holder within
three days of such Redemption Event, may redeem, in cash, the Warrants at a
redemption price of $.01 per Warrant. For purposes hereof, a "Redemption Event"
shall have occurred at such time as the Closing Bid Price for the Common Stock
is equal to no less than two times the Purchase Price on each of no less than
twenty (20) consecutive trading days for the Common Stock. The holder of the
Warrant shall be entitled to exercise this Warrant in the manner provided in
Section 2 hereof at any time after receipt of the redemption notice, but prior
to the redemption of this Warrant by the Company.

                  13.      REMEDIES; SPECIFIC PERFORMANCE. The Company
stipulates that there would be no adequate remedy at law to the Holder of this
Warrant in the event of any default or threatened default by the Company in the
performance of or compliance with any of the terms of this Warrant and
accordingly, the Company agrees that, in addition to any other remedy to which
the Holder may be entitled at law or in equity, the Holder shall be entitled to
seek to compel specific performance of the obligations of the Company under this
Warrant, without the posting of any bond, in accordance with the terms and
conditions of this Warrant in any court of the United States or any State
thereof having jurisdiction, and if any action should be brought in equity to
enforce any of the provisions of this Warrant, the Company shall not raise the
defense that there is an adequate remedy at law. Except as otherwise provided by
law, a delay or omission by the Holder hereof in exercising any right or remedy
accruing upon any such breach shall not impair the right or remedy or constitute
a waiver of or acquiescence in any such breach. No remedy shall be exclusive of
any other remedy. All available remedies shall be cumulative.

                  14.      NO RIGHTS OR LIABILITIES AS SHAREHOLDER. Nothing
contained in this Warrant shall be construed as conferring upon the Holder
hereof any rights as a stockholder of the Company or as imposing any obligation
on the Holder to purchase any securities or as imposing any liabilities on the
Holder as a stockholder of the Company, whether such obligation or liabilities
are asserted by the Company or by creditors of the Company.

                  15.      NOTICES. Any notices, consents, waivers or other
communications required or permitted to be given hereunder must be in writing
and will be deemed to have been delivered (i) upon receipt, when delivered
personally; (ii) upon receipt, when sent by facsimile, (iii) three days after
being sent by U.S. certified mail, return receipt requested, or (iv) one
Business Day after deposit with a nationally

                                      -18-
<PAGE>

recognized overnight delivery service, in each case properly addressed to the
party to receive the same. The addresses and facsimile numbers for such
communications shall be:

                  If to the Company:

                           DAMARK International, Inc.
                           7101 Winnetka Avenue
                           Brooklyn Park, Minnesota 55428
                           Telephone:     763-531-0066
                           Facsimile:     763-531-0481
                           Attention:     Mark A. Cohn, Chairman and Chief
                           Executive Officer

                  If to a Holder, to its address and facsimile number on the
register maintained by the Company. Each party shall provide five days' prior
written notice to the other party of any change in address or facsimile number.
Notwithstanding the foregoing, the exercise of any Warrant shall be effective in
the manner provided in Section 2.

                  16.      AMENDMENTS. This Warrant and any term hereof may not
be amended, modified, supplemented or terminated, and waivers or consents to
departures from the provisions hereof may not be given, except by written
instrument duly executed by the party against which enforcement of such
amendment, modification, supplement, termination or consent to departure is
sought.

                  17.      DESCRIPTIVE HEADINGS, ETC. The headings in this
Warrant are for convenience of reference only and shall not limit or otherwise
affect the meaning of terms contained herein. Unless the context of this Warrant
otherwise requires: (1) words of any gender shall be deemed to include each
other gender; (2) words using the singular or plural number shall also include
the plural or singular number, respectively; (3) the words "hereof", "herein"
and "hereunder" and words of similar import when used in this Warrant shall
refer to this Warrant as a whole and not to any particular provision of this
Warrant, and Section and paragraph references are to the Sections and paragraphs
of this Warrant unless otherwise specified; (4) the word "including" and words
of similar import when used in this Warrant shall mean "including, without
limitation," unless otherwise specified; (5) "or" is not exclusive; and (6)
provisions apply to successive events and transactions.

                  18.      GOVERNING LAW. This Warrant shall be governed by, and
construed in accordance with, the laws of the State of New York (without giving
effect to the conflict of laws principles thereof).

                  19.      JUDICIAL PROCEEDINGS. Any legal action, suit or
proceeding brought against the Company with respect to this Warrant may be
brought in any federal court of the Southern District of New York or any state
court located in New York County, State of New York, and by execution and
delivery of this Warrant, the Company

                                      -19-
<PAGE>

hereby irrevocably and unconditionally waives any claim (by way of motion, as a
defense or otherwise) of improper venue, that it is not subject personally to
the jurisdiction of such court, that such courts are an inconvenient forum or
that this Warrant or the subject matter may not be enforced in or by such court.
The Company hereby irrevocably and unconditionally consents to the service of
process of any of the aforementioned courts in any such action, suit or
proceeding by the mailing of copies thereof by registered or certified mail,
postage prepaid, at its address set forth or provided for in Section 15, such
service to become effective 10 days after such mailing. Nothing herein contained
shall be deemed to affect the right of any party to serve process in any manner
permitted by law or commence legal proceedings or otherwise proceed against any
other party in any other jurisdiction to enforce judgments obtained in any
action, suit or proceeding brought pursuant to this Section. The Company
irrevocably submits to the exclusive jurisdiction of the aforementioned courts
in such action, suit or proceeding.

                  20.      REGISTRATION RIGHTS AGREEMENT. The shares of Common
Stock (and Other Securities) issuable upon exercise of this Warrant (or upon
conversion of any shares of Common Stock issued upon such exercise) shall
constitute Registrable Securities (as such term is defined in the Registration
Rights Agreement). Each holder of this Warrant shall be entitled to all of the
benefits afforded to a holder of any such Registrable Securities under the
Registration Rights Agreement and such holder, by its acceptance of this
Warrant, agrees to be bound by and to comply with the terms and conditions of
the Registration Rights Agreement applicable to such holder as a holder of such
Registrable Securities.

                  21.      LIMITATION ON EXERCISE. Notwithstanding any provision
to the contrary contained herein, in no event shall the Holder be entitled to
exercise this Warrant, nor will the Company recognize such exercise, such that
upon giving effect to such exercise, the aggregate number of shares of Common
Stock then beneficially owned by the Holder and its "affiliates" as defined in
Rule 144 of the Act would exceed 4.99% of the total issued and outstanding
shares of the Common Stock following such exercise; PROVIDED, HOWEVER, that
Holder may elect to waive this restriction upon not less than sixty-one (61)
days prior written notice to the Company. For purposes of this Section,
beneficial ownership shall be calculated in accordance with Section 13(d) of the
Exchange Act.

                                     DAMARK INTERNATIONAL, INC.

                                     By:________________________________________
                                        Name:    Mark A. Cohn
                                        Title:   Chairman and CEO

                                      -20-
<PAGE>

                                                                       EXHIBIT A

                                    [FORM OF]
                           ELECTION TO PURCHASE SHARES
                         AND TRANSFER AGENT INSTRUCTIONS

                  The undersigned hereby irrevocably elects to exercise the
Warrant to purchase ____ shares of Common Stock, par value $.01 per share
("Common Stock"), of DAMARK INTERNATIONAL, INC. (the "Company") and hereby
[makes payment of $________ in consideration therefor] [or] [makes payment in
consideration therefor by reduction pursuant to Section 2.1(b)(iii) of the
Warrant of the number of shares of Common Stock otherwise issuable to the Holder
upon Warrant exercise by ______ shares] [or] [makes payment in consideration
therefor by delivery of the following Common Stock Certificates of the Company
pursuant to Section 2.1(b)(iv) of the Warrant, certificates of which are
attached hereto for cancellation _______ [list certificates by number and
amount]]. The undersigned hereby requests that certificates for such shares be
issued and delivered as follows:

ISSUE TO:_______________________________________________________________________
                                     (NAME)

________________________________________________________________________________
                          (ADDRESS, INCLUDING ZIP CODE)

________________________________________________________________________________
                  (SOCIAL SECURITY OR OTHER IDENTIFYING NUMBER)

DELIVER TO:_____________________________________________________________________
                                     (NAME)

________________________________________________________________________________
                          (ADDRESS, INCLUDING ZIP CODE)

                  If the number of shares of Common Stock purchased hereby is
less than the number of shares of Common Stock covered by the Warrant, the
undersigned requests that a new Warrant representing the number of shares of
Common Stock not so purchased be issued and delivered as follows:

ISSUE TO:_______________________________________________________________________
                                (NAME OF HOLDER)

________________________________________________________________________________
                          (ADDRESS, INCLUDING ZIP CODE)

DELIVER TO:_____________________________________________________________________
                                (NAME OF HOLDER)

________________________________________________________________________________
                          (ADDRESS, INCLUDING ZIP CODE)

Dated: _____________________       [NAME OF HOLDER]

                                   By___________________________________________
                                     Name:
                                     Title:

         __________________, as transfer agent and registrar of the Common
Stock, is hereby authorized and directed to issue the above number of shares of
Common Stock in

<PAGE>

the name of the above referenced entity or person and to deliver
the certificates representing such shares using an overnight delivery service.

                                   DAMARK INTERNATIONAL, INC.

                                   By:____________________________
                                      Name:
                                      Title:

                                                   EXHIBIT B to
                                                   Common Stock Purchase Warrant
                                                   -----------------------------

                              [FORM OF] ASSIGNMENT

                  FOR VALUE RECEIVED, the undersigned hereby sells, assigns, and
transfers unto the Assignee named below all of the rights of the undersigned to
purchase Common Stock, par value $.01 per share ("Common Stock") of DAMARK
INTERNATIONAL, INC., represented by the Warrant, with respect to the number of
shares of Common Stock set forth below:

<TABLE>
<CAPTION>
Name of Assignee                   Address                 No. of Shares
----------------                   -------                 -------------
<S>                                <C>                     <C>

</TABLE>

and does hereby irrevocably constitute and appoint ________ as Attorney to make
such transfer on the books of DAMARK INTERNATIONAL, INC. maintained for that
purpose, with full power of substitution in the premises.

Dated: ____________________         [NAME OF HOLDER]

                                    By _________________________________________
                                       Name:
                                       Title:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00015-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00015-of-00352.parquet"}]]